SEARCH

Search Details

TAKANO HIRONOBU

Hokkaido University Hospital Surgery Gastroenterological SurgeryⅡSpecially Appointed Assistant Professor

Researcher basic information

■ URL
researchmap URLホームページURL■ Various IDs
Researcher number
  • 40829339
J-Global ID

Research activity information

■ Papers
  • Relationship between remission rate of type 2 diabetes and skeletal muscle after laparoscopic sleeve gastrectomy.
    Hironobu Takano; Yuma Ebihara; Yuki Oe; Hideyuki Wada; Takeo Nitta; Akinobu Nakamura; Toshiaki Shichinohe; Satoshi Hirano
    Biomedical reports, 24, 6, 79, 79, Jun. 2026, [Peer-reviewed], [Lead author], [International Magazine]
    English, Scientific journal, Bariatric surgery can contribute to weight loss and the improvement of obesity-related diseases. Laparoscopic sleeve gastrectomy (LSG) is among the most frequently performed procedures worldwide, including in Japan. Skeletal muscle plays an essential role in energy metabolism and whole-body glucose homeostasis, and diabetes decreases insulin-induced glucose uptake in skeletal muscle. The present study investigated postoperative outcomes and factors related to type 2 diabetes (T2D) remission rates in LSG cases, including skeletal muscles. This retrospective study analyzed perioperative outcomes and factors associated with T2D remission after LSG, with a particular focus on skeletal muscle mass assessed by bioelectrical impedance analysis. LSG was performed on 90 patients between October 2016 and February 2024. First, the perioperative outcomes and weight loss effects in these 90 patients were examined. Muscle or skeletal mass perioperative factors were compared between patients with and without T2D remission. At 6 months after surgery, the median total weight loss was 21%, and the median excess weight loss was 52%. The rate of remission and improvement of T2D was 75%. The group that showed T2D remission generally had a significantly higher skeletal muscle mass or percentage throughout the preoperative and postoperative period (P<0.05). The remission rate of T2D after LSG was favorable, and a relationship was observed between T2D remission after LSG, and skeletal muscle mass before and after surgery.
  • Comparison of D2 and Non-D2 Lymphadenectomy in Older Patients (≥75 years) Undergoing Minimally Invasive Distal Gastrectomy for Gastric Cancer: A Multicenter Retrospective Propensity Score-matched Analysis.
    Yuma Ebihara; Noriaki Kyogoku; Hironobu Takano; Hideyuki Wada; Takeo Nitta; Daisuke Saikawa; Yoshiyuki Yamamura; Minoru Takada; Toshiaki Shichinohe; Satoshi Hirano
    Anticancer research, 46, 4, 2223, 2237, Apr. 2026, [Peer-reviewed], [International Magazine]
    English, Scientific journal, BACKGROUND/AIM: This multicenter retrospective cohort study with propensity score matching (PSM) evaluated the surgical outcomes and prognosis of minimally invasive distal gastrectomy (MIDG) with D2 lymphadenectomy (LND) in older patients (≥75 years) with gastric cancer (GC). PATIENTS AND METHODS: We retrospectively enrolled 988 patients who underwent MIDG for GC at five institutions between January 2018 and December 2024. Older patients with GC (cN+ or ≥cT2) were categorized into two groups: those who received D2 LND (D2 group) and those who did not (Non-D2 group). PSM was performed using the following covariates: age, sex, body mass index, American Society of Anesthesiologists physical status classification, surgical approach (laparoscopic or robotic), reconstruction method (Billroth I, Billroth II, or Roux-en-Y), adjuvant chemotherapy, and clinical T/N stage according to the Japanese Classification of Gastric Carcinoma. Surgical outcomes and prognoses were compared between groups. RESULTS: A total of 186 eligible patients were identified (D2: 74; Non-D2: 112), and 82 patients (41 per group) were included after matching. Operation time was significantly shorter in the Non-D2 group [D2: 349 min (176-507) vs. Non-D2: 285 min (138-458); p=0.025). The incidence of postoperative complications (Clavien-Dindo grade ≥II) was comparable between groups. The median follow-up was 23.3 months (range=1-79.4) in the D2 group and 26.2 months (range=1-79.5 months) in the Non-D2 group. No significant differences were observed in 5-year overall survival (D2: 47.7% vs. Non-D2: 34.6%; p=0.143) or 5-year relapse-free survival (RFS) (D2: 34.3% vs. Non-D2: 27.2%; p=0.578). Multivariable analysis identified pathological lymph node metastasis as an independent prognostic factor for RFS (hazard ratio= 3.553; 95% confidence interval=1.263-9.996; p=0.016). CONCLUSION: Among older patients (≥75 years) undergoing MIDG for GC, D2 LND was associated with longer operation time without significant differences in survival outcomes.
  • Safety, technical transferability, and oncological outcomes of multi-institutional robotic distal gastrectomy for gastric cancer: impact of surgeons qualified under the endoscopic surgical skill qualification system of the Japan Society for Endoscopic Surgery.
    Yuma Ebihara; Noriaki Kyogoku; Hironobu Takano; Hideyuki Wada; Takeo Nitta; Daisuke Saikawa; Yoshiyuki Yamamura; Minoru Takada; Toshiaki Shichinohe; Satoshi Hirano
    Journal of robotic surgery, 20, 1, 10 Mar. 2026, [Peer-reviewed], [International Magazine]
    English, Scientific journal, To evaluate the learning curve, clinical safety, and 3-year oncological outcomes of robotic distal gastrectomy (RDG) for gastric cancer (GC) during its multi-institutional introduction. We focused on the impact of surgeons who qualified under the Endoscopic Surgical Skill Qualification System (ESSQS) of the Japan Society for Endoscopic Surgery (JSES). We analyzed 251 consecutive patients who underwent RDG for GC at five affiliated institutions. The patients were divided into phases 1 (cases 1–59) and 2 (cases 60–251) based on a cumulative sum (CUSUM)-defined learning curve for operative time. Although the CUSUM analysis identified a statistical transition point at the 59th case, clinical outcomes, including complication rates (phase 1 vs. phase 2; Clavien–Dindo ≥ III: 8.5% vs. 3.1%, P = 0.102), were consistently stable from outset. Although phase 2 included advanced clinical stages (cStage II/III: 15.3% vs. 30.2%, P = 0.035) and older patients (median age: 67 vs. 72 years, P < 0.001), operative times remained stable (median: 340 vs. 331.5 min, P = 0.430), and the number of harvested lymph nodes significantly increased (median 33 vs. 37, P = 0.040). Three-year overall (93.1% vs. 93.0%, P = 0.878) and relapse-free (89.6% vs. 91.8%, P = 0.995) survival rates were comparable between the phases. Sub-analysis revealed that JSES ESSQS-qualified colorectal specialists achieved safety profiles comparable with those of gastric specialists, despite longer operative times. RDG can be safely performed without early-phase risk when led by JSES ESSQS-qualified surgeons. Their high baseline proficiency ensures stable clinical safety and favorable oncological outcomes, even as indications expand to complex cases.
  • Minimally invasive abdominal and left thoracic approach (MALTA) for Siewert type II esophagogastric junction adenocarcinoma: A retrospective cohort study of perioperative and oncologic outcomes.
    Takeo Nitta; Yuma Ebihara; Ryo Takagi; Hironobu Takano; Saseem Poudel; Hideyuki Wada; Toshiaki Shichinohe; Satoshi Hirano
    Surgical endoscopy, 40, 1, 586, 597, Jan. 2026, [Peer-reviewed], [International Magazine]
    English, Scientific journal, BACKGROUND: The optimal surgical approach for Siewert type II adenocarcinoma of the esophagogastric junction (AEG) remains controversial because of the complex lymphatic spread and anatomical constraints. We previously developed a novel minimally invasive abdominal and left thoracic approach (MALTA) to overcome the limitations of conventional techniques. This study aimed to provide an updated analysis of MALTA with extended follow-up period compared with our initial report. METHOD: A retrospective review was conducted on 16 consecutive patients who underwent MALTA for Siewert type II AEG between 2013 and 2023. The procedure combined laparoscopic gastrectomy and thoracoscopic lower mediastinal esophagectomy with intrathoracic reconstruction, both of which were performed without intraoperative repositioning. Perioperative outcomes, postoperative complications, and survival rates were analyzed. The Kaplan-Meier method was used to estimate overall survival (OS) and disease-free survival (DFS). The primary outcome was feasibility and safety (R0 resection rate and postoperative complications). Secondary outcomes included OS and DFS. RESULTS: R0 resection was achieved in all patients. The median operative time was 438 min, and median blood loss was 28 mL. Postoperative complications occurred in 31.3% of the patients, including anastomotic leakage (12.5%) and empyema (18.8%). No in-hospital deaths or respiratory complications were reported. The median follow-up duration was 51 months. The 1-, 3-, and 5-year OS rates were 87.5% (95% confidence interval [CI], 61.4-96.9), 67.7% (95% CI, 41.8-85.9), and 60.2% (95% CI, 34.7-81.1), respectively. The DFS rates were 68.8% (95% CI, 43.3-86.4), 56.3% (95% CI, 32.4-77.5), and 42.9% (95% CI, 21.5-67.3), respectively. CONCLUSIONS: MALTA appears to be a feasible, safe, and minimally invasive option for Siewert type II AEG, enabling stable intrathoracic anastomosis without patient repositioning. These results suggest its potential utility in achieving favorable perioperative and survival outcomes.
  • Male Sex as a Risk Factor for Perioperative Morbidity and Recurrence Following Minimally Invasive Distal Gastrectomy for Gastric Cancer: A Propensity Score Matching Analysis.
    Yuma Ebihara; Noriaki Kyogoku; Hironobu Takano; Hideyuki Wada; Takeo Nitta; Daisuke Saikawa; Yoshiyuki Yamamura; Minoru Takada; Toshiaki Shichinohe; Satoshi Hirano
    In vivo (Athens, Greece), 40, 2, 992, 1006, 2026, [Peer-reviewed], [International Magazine]
    English, Scientific journal, BACKGROUND/AIM: This study aimed to investigate the effect of sex-related differences on surgical outcomes, postoperative complications, and prognosis in patients undergoing minimally invasive distal gastrectomy (MIDG) for gastric cancer (GC). PATIENTS AND METHODS: We retrospectively analyzed 988 patients who underwent MIDG for GC at five institutions between January 2018 and December 2024. The patients were categorized according to sex (male or female). To minimize selection bias, propensity score matching (PSM) was performed using the following covariates: age, body mass index, the American Society of Anesthesiologists physical status classification, surgical approach (laparoscopic or robotic), reconstruction method, adjuvant chemotherapy, clinical stage, postoperative complications (Clavien-Dindo classification: CD), and prognoses, including overall survival (OS), relapse-free survival (RFS), and Cancer-Specific Survival (CSS). RESULTS: Even after the PSM, male patients demonstrated significantly worse outcomes in surgical and long-term settings. Compared with the females, males had a longer median operation time (293 min vs. 274 min, p<0.001) and greater blood loss (median 5 ml vs. 0 ml, p<0.001). Incidence of postoperative complications (CD II) was significantly higher in the male group (15.4% vs. 9.5%, p=0.037) than that in the female group. Multivariate logistic regression analysis identified male sex as an independent risk factor for postoperative complications (odds ratio: 1.727; 95% confidence interval=1.032-2.939; p=0.037). In a multivariate Cox regression analysis, male sex was as an independent risk factor for poorer RFS. CONCLUSION: Male patients undergoing MIDG face significantly higher risks of postoperative complications and cancer recurrence than female patients, independent of baseline clinical and pathological factors.
  • Surgical and Oncologic Outcomes of Robotic Versus Laparoscopic Distal Gastrectomy for Gastric Cancer: Real-World Data From a Multi-Institutional Propensity Score-Matched Study.
    Noriaki Kyogoku; Yuma Ebihara; Takeo Nitta; Hideyuki Wada; Hironobu Takano; Minoru Takada; Yoshiyuki Yamamura; Daisuke Saikawa; Toshiaki Shichinohe; Satoshi Hirano
    Asian journal of endoscopic surgery, 19, 1, e70274, 2026, [Peer-reviewed], [Domestic magazines]
    English, Scientific journal, INTRODUCTION: Robotic gastrectomy (RG) has been increasingly adopted for gastric cancer (GC). Although high-volume centers report superior outcomes compared with laparoscopic gastrectomy (LG), real-world evidence remains limited. This study compared short- and long-term outcomes of robotic distal gastrectomy (RDG) and laparoscopic distal gastrectomy (LDG) using propensity score matching. METHODS: Patients who underwent curative RDG or LDG between April 2018 and December 2024 were retrospectively reviewed. Propensity score matching was performed based on demographics, clinical factors, surgical procedures, pathological stage (Japanese Classification of Gastric Carcinoma), and perioperative chemotherapy. Surgical, postoperative, and oncological outcomes were compared. RESULTS: Among 821 patients, 228 matched pairs were analyzed. Operative time was longer in the RDG group than in the LDG group (median 333 vs. 272.5 min, p < 0.0001). RDG was associated with lower rates of postoperative intra-abdominal infectious complications, both overall and Clavien-Dindo grade ≥ II. Postoperative hospital stay was shorter in the RDG group (median 9 vs. 10 days, p = 0.0126). In patients with pathological stage III disease, operative time did not differ significantly between groups. The maximum postoperative serum C-reactive protein level was lower in the RDG group, indicating a reduced inflammatory response. Overall and recurrence-free survival did not differ significantly between groups. CONCLUSION: RDG was associated with fewer intra-abdominal infections, shorter hospital stay, and reduced inflammatory response compared with LDG. For advanced GC (pStage III), RDG did not increase operative time and may provide clinical advantages. RG may be particularly beneficial for patients with advanced disease.
  • Comparison of Clinical Outcomes Between Billroth-I and Roux-en-Y Reconstruction Following Minimally Invasive Distal Gastrectomy for Gastric Cancer: A Multicenter Retrospective Propensity Score-Matched Analysis.
    Yuma Ebihara; Noriaki Kyogoku; Hironobu Takano; Hideyuki Wada; Takeo Nitta; Daisuke Saikawa; Yoshiyuki Yamamura; Minoru Takada; Toshiaki Shichinohe; Satoshi Hirano
    Surgical laparoscopy, endoscopy & percutaneous techniques, 35, 6, 01 Dec. 2025, [Peer-reviewed], [International Magazine]
    English, Scientific journal, PURPOSE: Gastric cancer (GC) is the third leading cause of cancer deaths, with surgery as the primary treatment; however, the outcomes of different types of surgeries still need to be understood further. This study evaluated the surgical outcomes and prognosis after minimally invasive distal gastrectomy (MIDG) for GC in a multicenter retrospective cohort using propensity score matching. METHODS: This study retrospectively enrolled 688 patients who underwent curative MIDG for GC at five institutions between January 2018 and December 2024. Patients were categorized into Billroth-I reconstruction (B-I) and Roux-en-Y (R-Y) reconstruction groups. Propensity score matching was performed using the following covariates: age, sex, body mass index, American Society of Anesthesiologists physical status, extent of lymph node dissection, Japanese Classification of Gastric Carcinoma stage, neoadjuvant chemotherapy, and adjuvant chemotherapy. Surgical outcomes and prognoses were compared. RESULTS: Three hundred propensity score-matched pairs were identified. The R-Y group had longer median operation time [309 (131 to 531) min vs. 265 (126 to 532) min; P <0.001], longer postoperative hospital stay [10 (5 to 110) d vs. 10 (5 to 43) d; P =0.042], and greater median blood loss ( P =0.047) than the B-I group. Complications of Clavien-Dindo (CD) grade II ( P <0.001) and grade III ( P =0.027) were more frequent in the R-Y group than in the B-I group. Five-year overall survival (OS) was significantly higher in the B-I group than in the R-Y group (91.1% vs. 83.4%; P =0.019), whereas 5-year relapse-free survival (RFS) showed no significant difference between these 2 groups ( P =0.056). Independent prognostic factors included reconstruction method, postoperative complications (≥CD III), and lymph node metastasis (pN) for OS and age (≥80), pT, and pN for RFS. CONCLUSIONS: Patients who underwent R-Y reconstruction had more frequent postoperative complications than those who underwent B-I reconstruction after MIDG. Although not significantly associated with RFS, these complications may affect OS. The findings of this study could help develop strategies for improving GC treatment.
  • Postoperative Complications, Including Minor Complications, Worsen Prognosis After Laparoscopic Distal Gastrectomy for Gastric Cancer.
    Yuma Ebihara; Noriaki Kyogoku; Hironobu Takano; Hideyuki Wada; Takeo Nitta; Daisuke Saikawa; Yoshiyuki Yamamura; Minoru Takada; Toshiaki Shichinohe; Satoshi Hirano
    Anticancer research, 45, 12, 5619, 5631, Dec. 2025, [Peer-reviewed], [International Magazine]
    English, Scientific journal, BACKGROUND/AIM: The relationship between postoperative complications and prognosis after laparoscopic distal gastrectomy (LDG) for gastric cancer (GC) remains controversial. This study evaluated this association using propensity score-matched analysis. PATIENTS AND METHODS: We analyzed data of 590 patients who underwent curative LDG for GC at five institutions between January 2018 and December 2024. Patients were categorized into non-complication and complication groups (non-CG and CG, respectively), with complications defined as Clavien-Dindo grade ≥II (CD ≥II). Minor complications were defined as CD grades I or II, and major complications were defined as CD grades ≥III. Propensity score matching (PSM) was performed using the following covariates: age, sex, body mass index, American Society of Anesthesiologists physical status, extent of lymph node dissection, reconstruction method, Japanese Classification of Gastric Carcinoma stage, neoadjuvant chemotherapy, and adjuvant chemotherapy. Survival curves were compared using the log-rank test, and multivariate analysis was performed using the Cox proportional hazard models. RESULTS: Overall incidence of postoperative complications (CD ≥II) was 14.9% (88/590 patients). After the PSM (85 pairs), the CG group had a significantly longer postoperative hospital stay than the non-CG group [median (range), 18 (7-110) days vs. 9 (5-18) days; p<0.001]. Five-year overall survival (OS) rate was 90.7% in the non-CG group and 70.4% in the CG group (p=0.009), and 5-year relapse-free survival rate was 87.7% in the non-CG group and 70.9% in the CG group (p=0.027). Multivariable analysis identified age ≥80 years, postoperative complications (CD ≥II), and lymph node metastasis (pN) as independent prognostic factors for OS. CONCLUSION: Reducing the incidence of postoperative complications (CD ≥II) may improve prognosis in patients with GC undergoing LDG, contributing to better treatment strategies for GC.
  • Effectiveness of haptic feedback during local and remote robotic surgery: single-blind cadaveric study.
    Hironobu Takano; Yuma Ebihara; Satoshi Hirano; Toshiaki Shichinohe; Soichi Murakami; Hajime Morohashi; Eiji Oki; Kenichi Hakamada; Akinobu Taketomi; Norihiko Ikeda; Masaki Mori
    Journal of robotic surgery, 19, 1, 662, 662, 04 Oct. 2025, [Peer-reviewed], [Lead author], [International Magazine]
    English, Scientific journal, BACKGROUND: Robotic surgery has rapidly evolved, with telesurgery emerging as a promising extension. However, the lack of haptic feedback remains a key limitation, potentially compromising surgical safety. This study aimed to evaluate the impact of haptic feedback on surgical performance in both local and remote robotic settings using a cadaver model. METHODS: Six gastrointestinal surgeons were assigned to local or remote groups and performed standardized bowel traction tasks using the Saroa™ surgical robot. Haptic feedback was tested at three levels: none (0), moderate (0.5), and full (1.0). Each participant completed the task three times under each condition. Task completion time, grip force, and forceps path length were measured. RESULTS: Grip force significantly decreased with increasing haptic feedback levels, particularly in the non-dominant (left) hand. No significant differences in task completion time or forceps path length were found across feedback levels or between local and remote settings, except for a longer right-hand path length in the remote group at feedback level 0.5. CONCLUSIONS: Haptic feedback reduced grip force in both local and remote robotic surgery, suggesting enhanced surgical safety. However, its effect on efficiency metrics was limited. These findings support the integration of haptic feedback in telesurgical systems, although further validation with complex procedures and more participants is warranted.
  • Feasibility of Detecting Fluorescent Marking Clip with Novel Fluorescence Detection System in Minimally Invasive Stomach and Esophageal Surgery.
    Hideyuki Wada; Yuma Ebihara; Hironobu Takano; Mariko Hayashi; Takeo Nitta; Toshiaki Shichinohe; Satoshi Hirano
    Journal of clinical medicine, 14, 3, 23 Jan. 2025, [Peer-reviewed], [International Magazine]
    English, Scientific journal, Background: Determining the optimal resection line for an organ that cannot be palpated is crucial, but challenging, in minimally invasive gastrointestinal (GI) surgery. Therefore, there is an urgent need to establish the most effective method for tumor localization. We hypothesize that our novel near-infrared (NIR) fluorescence detection system will enable the highly accurate detection of fluorescent clips marking GI cancer. Methods: Twenty-five patients with gastric cancer, esophagogastric junctional cancer, or esophageal cancer will be enrolled. NIR fluorescent clips will be placed endoscopically around the tumor on the day before surgery. Patients in whom clip dislodgement is confirmed by preoperative abdominal radiography will be excluded. The clips will be placed before the transection of the organ, and those on the surgical specimen will be observed after transection using both the novel NIR fluorescence detection system and an existing NIR fluorescence imaging system. The detection rate and time, the fluorescence intensity, surgical margins, and adverse events will be evaluated. This study has been registered in the Japan Registry of Clinical Trials, with the code jRCTs012240043. (Expected) Results: As the novel fluorescence detection system allows for higher-sensitivity detection by analyzing the spectral characteristics of fluorescence and measuring the peak values, we anticipate that this new system will detect the fluorescent clips with high accuracy. Conclusions: This study aims to establish a novel tumor-marking method using fluorescent clips and a new detection system that can be easily applied in various medical facilities.
  • Field experiment of a telesurgery system using a surgical robot with haptic feedback.
    Mitsuhiko Ota; Eiji Oki; Tomonori Nakanoko; Yasushi Tanaka; Satoshi Toyota; Qingjiang Hu; Yu Nakaji; Ryota Nakanishi; Koji Ando; Yasue Kimura; Yuichi Hisamatsu; Koshi Mimori; Yoshiya Takahashi; Hajime Morohashi; Takahiro Kanno; Kotaro Tadano; Kenji Kawashima; Hironobu Takano; Yuma Ebihara; Masaki Shiota; Junichi Inokuchi; Masatoshi Eto; Tomoharu Yoshizumi; Kenichi Hakamada; Satoshi Hirano; Masaki Mori
    Surgery today, 54, 4, 375, 381, Apr. 2024, [Peer-reviewed], [Domestic magazines]
    English, Scientific journal, PURPOSE: To verify the usefulness of haptic feedback in telesurgery and improve the safety of telerobotic surgery. METHODS: The surgeon's console was installed at two sites (Fukuoka and Beppu; 140 km apart), and the patient cart was installed in Fukuoka. During the experiment, the surgeon was blinded to the haptic feedback levels and asked to grasp the intestinal tract in an animal model. The surgeon then performed the tasks at each location. RESULTS: No marked differences in task accuracy or average grasping force were observed between the surgeon locations. However, the average task completion time was significantly longer, and the system usability scale (SUS) was significantly lower rating for remote operations than for local ones. No marked differences in task accuracy or task completion time were observed between the haptic feedback levels. However, with haptic feedback, the organ was grasped with a significantly weaker force than that without it. Furthermore, with haptic feedback, experienced surgeons in robotic surgery tended to perform an equivalent task with weaker grasping forces than inexperienced surgeons. CONCLUSION: The haptic feedback function is a tool that allows the surgeon to perform surgery with an appropriate grasping force, both on site and remotely. Improved safety is necessary in telesurgery; haptic feedback will thus be an essential technology in robotic telesurgery going forward.
  • Tele-robotic distal gastrectomy with lymph node dissection on a cadaver.
    Yuma Ebihara; Satoshi Hirano; Yo Kurashima; Hironobu Takano; Kunishige Okamura; Soichi Murakami; Toshiaki Shichinohe; Hajime Morohashi; Eiji Oki; Kenichi Hakamada; Norihiko Ikeda; Masaki Mori
    Asian journal of endoscopic surgery, 17, 1, e13246, Jan. 2024, [Peer-reviewed], [Domestic magazines]
    English, Scientific journal, The purpose of this study is to evaluate the performance of tele-robotic distal gastrectomy (tele-RDG) with lymph node dissection (LND) using a novel Japanese-made surgical robot hinotori™ (Medicaroid, Kobe, Japan) in a cadaver with a presumptive gastric cancer. The Cadaveric Anatomy and Surgical Training Laboratory (CAST-Lab.) at Hokkaido University and Kushiro City General Hospital (KCGH) are connected by a guaranteed type line (1 Gbps), and the distance between the two facilities is 250 km. A patient cart was installed at CAST-Lab, and a surgeon cockpit was installed at KCGH. Tele-RDG with D2 LND was performed on an adult human cadaver. In all surgical processes, the communication environment was stable without image degradation, and the mean round trip time was 40 milliseconds (36.5-55 milliseconds). For tele-RDG with D2 LND, the operation time was 199 minutes without any technical problems. Tele-RDG using hinotori™ was feasible and similar to local robotic RDG.
  • Telesurgery and telesurgical support using a double-surgeon cockpit system allowing manipulation from two locations.
    Eiji Oki; Mitsuhiko Ota; Tomonori Nakanoko; Yasushi Tanaka; Satoshi Toyota; Qingjiang Hu; Yu Nakaji; Ryota Nakanishi; Koji Ando; Yasue Kimura; Yuichi Hisamatsu; Koshi Mimori; Yoshiya Takahashi; Hajime Morohashi; Takahiro Kanno; Kotaro Tadano; Kenji Kawashima; Hironobu Takano; Yuma Ebihara; Masaki Shiota; Junichi Inokuchi; Masatoshi Eto; Tomoharu Yoshizumi; Kenichi Hakamada; Satoshi Hirano; Masaki Mori
    Surgical endoscopy, 37, 8, 6071, 6078, Aug. 2023, [Peer-reviewed], [International Magazine]
    English, Scientific journal, BACKGROUND: Although several studies on telesurgery have been reported globally, a clinically applicable technique has not yet been developed. As part of a telesurgical study series conducted by the Japan Surgical Society, this study describes the first application of a double-surgeon cockpit system to telesurgery. METHODS: Surgeon cockpits were installed at a local site and a remote site 140 km away. Three healthy pigs weighing between 26 and 29 kg were selected for surgery. Non-specialized surgeons performed emergency hemostasis, cholecystectomy, and renal vein ligation with remote assistance using the double-surgeon cockpits and specialized surgeons performed actual telesurgery. Additionally, the impact of adding internet protocol security (IPsec) encryption to the internet protocol-virtual private network (IP-VPN) line on communication was evaluated to address clinical security concerns. RESULTS: The average time required for remote emergency hemostasis with the double-surgeon cockpit system was 10.64 s. A non-specialized surgeon could safely perform cholecystectomy or renal vein ligation with remote assistance. Global Evaluative Assessment of Robotic Skills and System Usability Scale scores were higher for telesurgical support-assisted surgery by a non-specialized surgeon using the double-surgeon cockpits than for telesurgery performed by a specialized surgeon without the double-cockpit system. Adding IPsec encryption to the IP-VPN did not have a significant impact on communication. CONCLUSION: Telesurgical support through our double-surgeon cockpit system is feasible as first step toward clinical telesurgery.
  • Technical evaluation of robotic tele-cholecystectomy: a randomized single-blind controlled pilot study.
    Yuma Ebihara; Satoshi Hirano; Hironobu Takano; Takahiro Kanno; Kenji Kawashima; Hajime Morohashi; Eiji Oki; Kenichi Hakamada; Shigeo Urushidani; Masaki Mori
    Journal of robotic surgery, 17, 3, 1105, 1111, Jun. 2023, [Peer-reviewed], [International Magazine]
    English, Scientific journal, Although robotic telesurgery is growing in popularity, the benefits of telesurgery compared to local surgery are unclear. This study aimed to evaluate the performance of robotic tele-cholecystectomy with a commercial line using the Saroa™ (Riverfield, Inc., Tokyo, Japan) system. The operation rooms of the Hokkaido University Hospital and Kushiro City General Hospital were connected using a best effort-type line (1 Gbps), with a distance of 250 km between the two hospitals. In this experimental single-blind randomized crossover trial, eight expert robotic surgeons performed robotic cholecystectomy in an artificial organ model using the Saroa™ system and were randomized to begin with either local surgery or telesurgery. All surgeons were assessed on task completion time, total path length of the right- and left- hand forceps and camera, Global Evaluative Assessment of Robotic Skills (GEARS), Global Operative Assessment of Laparoscopic Skills (GOALS), and System and Piper Fatigue Scale-12 (PFS-12). In all experiments, the communication environment was stable and the mean communication delay was 8 ms (3-31 ms). All tele-cholecystectomies were performed safely. There was no significant difference in completion time (P = 0.495), score of GEARS (P = 0.258), GOALS (P = 0.180), or PFS-12 (P = 0.528) between local surgery and telesurgery. The total path of the forceps tended to be longer in tele-cholecystectomy, particularly with significantly longer left-hand forceps total path length (P = 0.041). Robotic tele-cholecystectomy using a commercial line can be performed safely as same as local robotic surgery, but the total path of the left-hand forceps was prolonged in robotic tele-cholecystectomy due to overshoot. Therefore, a solution for overshooting will be required in the future.
  • Dedifferentiated liposarcoma primary to the chest wall with spontaneous shrinking: report of a case.
    Yuki Itagaki; Akira Fukunaga; Hironobu Takano; Kazuyuki Yamamoto; Kohei Nishigami; Tatsunosuke Ichimura; Hiroto Manase; Masahiko Obata; Tatsuya Kato; Satoshi Hirano
    Surgical case reports, 9, 1, 26, 26, 15 Feb. 2023, [Peer-reviewed], [Domestic magazines]
    English, Scientific journal, An 80-year-old man presented to our emergency department complaining of a mass on the right side of his chest and pain in the right flank of his back. A chest computed tomography (CT) scan showed a relatively heterogenous oval-shaped tumor measuring 7.5 × 6.0 cm eroded to the 8th rib, with slightly dense fluid accumulation inside and calcification of the tumor wall. A 1-month follow-up CT scan showed spontaneous shrinkage of the tumor. The tumor was completely excised from the thoracic wall and the wall was reconstructed with a polytetrafluoroethylene mesh. Pathological examination showed coagulation necrosis in the chest wall tumor, but immunohistochemical staining revealed murine double minute 2- and Cyclin-dependent kinase 4-positive cells with irregular nuclear size and bizarre morphology. Therefore, dedifferentiated liposarcoma (DDLPS) was the final pathological diagnosis. Remarkable infiltration of CD8+ lymphocytes into the tumor was observed, along with a 90% positive ratio for programmed cell death-ligand 1. The patient has been followed-up for 1 year without any recurrence, despite not receiving any additional treatment. Liposarcoma is one of the most common types of soft tissue sarcomas; however, spontaneous regression of primary DDLPS arising from the chest wall is extremely rare. Herein, we report a case of DDLPS primary to the chest wall with spontaneous regression, probably due to a spontaneously induced T cell response.
  • Identification of antibody against wingless‑type MMTV integration site family member 7B as a biliary cancer tumor marker.
    Mizuna Takahashi; Takahiro Tsuchikawa; Takaki Hiwasa; Toru Nakamura; Koji Hontani; Toshihiro Kushibiki; Kazuho Inoko; Hironobu Takano; Yutaka Hatanaka; Kazuyuki Matsushita; Hisahiro Matsubara; Tyuji Hoshino; Masayuki Ohtsuka; Hideaki Shimada; Kimitaka Tanaka; Yoshitsugu Nakanishi; Toshimichi Asano; Takehiro Noji; Keisuke Okamura; Toshiaki Shichinohe; Satoshi Hirano
    Oncology reports, 49, 2, Feb. 2023, [Peer-reviewed], [International Magazine]
    English, Scientific journal, Biliary cancer has a poor prognosis due to a lack of specific biomarkers and difficulty in diagnosis. The present study aimed to identify serum tumor markers for the diagnosis of biliary cancer via serological identification of antigens by recombinant cDNA expression cloning. Wingless‑type MMTV integration site family, member 7 (WNT7B) was identified as a target antigen, suggesting the presence of serum antibodies against this antigen. Deletion mutants were then prepared to evaluate the response to serum antibodies. When serum antibody levels against WNT7B deletion mutants (WNT7B-92‑2, -92‑260, 2-260 and 184-260) were examined using amplified luminescence proximity homogeneous assay‑linked immunosorbent assay, the levels of the antibody against WNT7B with amino acids 184‑260 were higher in patients with biliary cancer than in healthy donors. Therefore, the region covering residues 184‑260 of WNT7B was decomposed to generate seven peptides, and the levels of antibodies against these peptides were measured. Among them, the levels of antibodies against WNT7B234‑253 and WNT7B244‑260 were higher in patients with biliary cancers than in healthy donors (WNT7B234‑253, P=0.0009; WNT7B244‑260, P=0.0005). The levels of the antibody against the former were specifically high in patients with biliary cancer but not in those with esophageal, gastric, colorectal, pancreatic, or breast cancer. Furthermore, analysis by the cutoff value of WNT7B234‑253 defined by ROC showed a high sensitivity of 70% in patients with biliary cancer. Therefore, the serum levels of the antibody against WNT7B234‑253 may be useful as a marker for biliary cancer diagnosis.
  • Laparoscopic cholecystectomy after transcatheter arterial embolisation for haemobilia due to a pseudoaneurysm in the gallbladder: A case report.
    Yuki Itagaki; Kazuyuki Yamamoto; Tomoki Kikuchi; Hironobu Takano; Kohei Nishigami; Akira Fukunaga; Tatsunosuke Ichimura; Hiroto Manase; Satoshi Hirano
    SAGE open medical case reports, 11, 2050313X231166777, 2023, [Peer-reviewed], [International Magazine]
    English, Scientific journal, Pseudoaneurysms of the cystic artery are a rare but significant complication of acute cholecystitis. Laparoscopic cholecystectomy may be a safe alternative to open cholecystectomy in such cases. We report the case of a female patient in her seventies, who presented with anaemia, jaundice, and hepatic dysfunction during hospitalisation for right knee pyogenic arthritis. The patient had no pain in the right upper quadrant. Her serum haemoglobin level was 6.5 g/dL, and upper gastrointestinal endoscopy revealed no abnormalities. Six days later, jaundice worsened, and endoscopic retrograde cholangiopancreatography revealed bloody bile. An endoscopic biliary drainage tube was inserted at the discretion of the gastroenterology department. Contrast-enhanced computed tomography revealed a haematoma in the gallbladder and a pseudoaneurysm in the lateral wall of the gallbladder. On the same day, the endoscopic biliary drainage tube was replaced with an endoscopic nasobiliary drainage tube, which indicated the degree of haemorrhage and enabled lavage of the lumen in cases of obstruction. The next day, angiography revealed a pseudoaneurysm of the deep branch of the cystic artery and coil embolisation was performed at the periphery of the cystic artery. Uninterrupted laparoscopic cholecystectomy was performed. Although laparoscopic cholecystectomy is difficult when bleeding is uncontrolled, it was safely performed following haemostasis using transcatheter arterial embolisation. Laparoscopic cholecystectomy is feasible in haemodynamically stable patients with cystic artery pseudoaneurysms after transcatheter arterial embolisation.
  • Tele-assessment of bandwidth limitation for remote robotics surgery.
    Yuma Ebihara; Eiji Oki; Satoshi Hirano; Hironobu Takano; Mitsuhiko Ota; Hajime Morohashi; Kenichi Hakamada; Shigeo Urushidani; Masaki Mori
    Surgery today, 52, 11, 1653, 1659, Nov. 2022, [Peer-reviewed], [Domestic magazines]
    English, Scientific journal, PURPOSE: We investigated the communication bandwidth (CB) limitation for remote robotics surgery (RRS) using hinotori™ (Medicaroid, Kobe, Japan). METHODS: The operating rooms of the Hokkaido University Hospital and Kyushu University Hospital were connected using the Science Information NETwork (SINET). The minimum required CB for the RRS was verified by decreasing the CB from 500 to 100 Mbps. Ten surgeons were tested on a task (intracorporeal suturing) at different levels of video compression (VC) (VC1: 120 Mbps, VC2: 40 Mbps, VC3: 20 Mbps) with the minimum required CB, and assessed based on the task completion time, Global Evaluative Assessment of Robotic Skills (GEARS), and System and Piper Fatigue Scale-12 (PFS-12). RESULTS: Packet loss was observed at 3-7% and image degradation was observed at 145 Mbps CB. The task performance with VC1 was significantly worse than that with VC2 and VC3 according to the task completion time (VC1 vs VC2, P = 0.032; VC1 vs. VC3, P = 0.032), GEARS (VC1 vs VC2; P = 0.029, VC1 vs VC3; P = 0.031), and PFS-12 (VC1 vs. VC2; P = 0.032, VC1 vs. VC3; P = 0.032) with 145 Mbps. CONCLUSION: Our findings provide evidence that RRS using hinotori™ requires a CB ≥ 150 Mbps. We also found that when there is insufficient CB, RRS can be continued by compressing the image.
  • Therapeutic activity of retroviral replicating vector-mediated prodrug activator gene therapy for pancreatic cancer.
    Kazuho Inoko; Kei Hiraoka; Akihito Inagaki; Mizuna Takahashi; Toshihiro Kushibiki; Koji Hontani; Hironobu Takano; Shoki Sato; Shintaro Takeuchi; Toru Nakamura; Takahiro Tsuchikawa; Toshiaki Shichinohe; Harry E Gruber; Douglas J Jolly; Noriyuki Kasahara; Satoshi Hirano
    Cancer gene therapy, 25, 7-8, 184, 195, Aug. 2018, [Peer-reviewed], [International Magazine]
    English, Scientific journal, Toca 511, a retroviral replicating vector (RRV) encoding the yeast cytosine deaminase (yCD) prodrug activator gene, which mediates conversion of the prodrug 5-fluorocytosine (5-FC) to the anticancer drug 5-fluorouracil (5-FU), is currently being evaluated in Phase II/III clinical trials for glioma, and showing highly promising evidence of therapeutic activity. Here we evaluated RRV-mediated prodrug activator gene therapy as a new therapeutic approach for pancreatic ductal adenocarcinoma (PDAC). RRV spread rapidly and conferred significant cytotoxicity with prodrug in a panel of PDAC cells. Efficient intratumoral replication and complete inhibition of tumor growth upon 5-FC administration were observed in both immunodeficient and immunocompetent subcutaneous PDAC models. Biodistribution of RRV was highly restricted in normal tissues, especially in immunocompetent hosts. Tumor growth inhibition by Toca 511 followed by 5-FC was also confirmed in the orthotopic PDAC model. This study provides the first proof-of-concept for application of Toca 511 and Toca FC (extended release 5-FC) to the treatment of human PDAC, and provided support for inclusion of PDAC in a Phase I study evaluating Toca 511 in various systemic malignancies, (NCT02576665), which has recently been initiated.
  • Molecular targeting of cell-permeable peptide inhibits pancreatic ductal adenocarcinoma cell proliferation.
    Shoki Sato; Toru Nakamura; Toyomasa Katagiri; Takahiro Tsuchikawa; Toshihiro Kushibiki; Kouji Hontani; Mizuna Takahashi; Kazuho Inoko; Hironobu Takano; Hirotake Abe; Shintaro Takeuchi; Masato Ono; Shota Kuwabara; Kazufumi Umemoto; Tomohiro Suzuki; Osamu Sato; Yusuke Nakamura; Satoshi Hirano
    Oncotarget, 8, 69, 113662, 113672, 26 Dec. 2017, [Peer-reviewed], [International Magazine]
    English, Scientific journal, BACKGROUND: Chromosome 16 open reading frame 74 (C16orf74) is highly expressed in pancreatic ductal adenocarcinoma (PDAC) and is involved in cancer cell proliferation and invasion through binding to calcineurin (CN). Therefore, C16orf74 is a good target for the development of a PDAC treatment. A cell-permeable dominant-negative (DN) peptide that can inhibit the C16orf74/CN interaction was designed to examine whether this peptide can inhibit PDAC cell proliferation in vitro and in vivo. METHOD: TheDN-C16orf74 peptide, which corresponds to the portion of C16orf74 that interacts with CN, was synthesized, and we assessed its anti-tumor activity in proliferation assays with human PDAC cells and the underlying molecular signaling pathway. Using an orthotopic xenograft model of PDAC, we treated mice intraperitoneally with phosphate-buffered saline (PBS), control peptide, or DN-C16orf74 and analyzed the tumor-suppressive effects. RESULT: DN-C16orf74 inhibited the binding of C16orf74 to CN in an immunoprecipitation assay. DN-C16orf74 suppressed PDAC cell proliferation, and the level of suppression depended on the expression levels of C16orf74 in vitro. DN-C16orf74 also exhibited anti-tumor effects in orthotopic xenograft model. Furthermore, the tumor-suppressive effect was associated with inhibition of the phosphorylation of Akt and mTOR. CONCLUSION: The cell-permeable peptide DN-C16orf74 has a strong anti-tumor effect against PDAC in vitro and in vivo.
  • Identification of novel serum autoantibodies against EID3 in non-functional pancreatic neuroendocrine tumors.
    Koji Hontani; Takahiro Tsuchikawa; Takaki Hiwasa; Toru Nakamura; Takashi Ueno; Toshihiro Kushibiki; Mizuna Takahashi; Kazuho Inoko; Hironobu Takano; Satoshi Takeuchi; Hirotoshi Dosaka-Akita; Masaki Kuwatani; Naoya Sakamoto; Yutaka Hatanaka; Tomoko Mitsuhashi; Hideaki Shimada; Toshiaki Shichinohe; Satoshi Hirano
    Oncotarget, 8, 63, 106206, 106221, 05 Dec. 2017, [Peer-reviewed], [International Magazine]
    English, Scientific journal, Pancreatic neuroendocrine tumors (pNETs) are relatively rare heterogenous tumors, comprising only 1-2% of all pancreatic neoplasms. The majority of pNETs are non-functional tumors (NF-pNETs) that do not produce hormones, and as such, do not cause any hormone-related symptoms. As a result, these tumors are often diagnosed at an advanced stage because patients do not present with specific symptoms. Although tumor markers are used to help diagnosis and predict some types of cancers, chromogranin A, a widely used tumor marker of pNETs, has significant limitations. To identify novel NF-pNET-associated antigens, we performed serological identification of antigens by recombinant cDNA expression cloning (SEREX) and identified five tumor antigens (phosphatase and tensin homolog, EP300-interacting inhibitor of differentiation 3 [EID3], EH domain-containing protein 1, galactoside-binding soluble 9, and BRCA1-associated protein). Further analysis using the AlphaLISA® immunoassay to compare serum antibody levels revealed that antibody levels against the EID3 antigen was significantly higher in the patient group than in the healthy donor group (n = 25, both groups). In addition, higher serum anti-EID3 antibody levels in NF-pNET patients correlated with shorter disease-free survival. The AUC calculated by ROC analysis was 0.784 with moderate diagnostic accuracy. In conclusion, serum anti-EID3 antibody levels may be useful as a tumor marker for prediction of tumor recurrence in NF-pNETs.
  • Inhibition of Eph receptor A4 by 2,5-dimethylpyrrolyl benzoic acid suppresses human pancreatic cancer growing orthotopically in nude mice.
    Hironobu Takano; Toru Nakamura; Takahiro Tsuchikawa; Toshihiro Kushibiki; Kouji Hontani; Kazuho Inoko; Mizuna Takahashi; Shoki Sato; Hirotake Abe; Shintaro Takeuchi; Nagato Sato; Kei Hiraoka; Hiroshi Nishihara; Toshiaki Shichinohe; Satoshi Hirano
    Oncotarget, 6, 38, 41063, 76, 01 Dec. 2015, [Peer-reviewed], [Lead author], [International Magazine]
    English, Scientific journal, Ephrin receptor A4 (EphA4) is overexpressed in human pancreatic adenocarcinoma (PDAC) and activate cell growth. Recent studies have identified small molecules that block EphA4. In this study, we investigated the correlation between EphA4 expression and the prognosis of patients with PDAC. We also examined the cytostatic efficacy of 2,5-dimethylpyrrolyl benzoic acid (compound 1), a small molecule that blocks EphA4, in PDAC cells. Overall survival of patients with EphA4 positivity was significantly shorter than that of patients with EphA4 negativity (P = 0.029). In addition, multivariate analysis revealed that EphA4 expression was an independent prognostic factor in PDAC patients (P = 0.039). Compound 1 showed a cytostatic efficacy in PDAC cells expressing EphA4 in vitro and in vivo. Our study indicated that compound 1 suppressed both EphA4 and Akt phosphorylations, and induced apoptosis in PDAC cells expressing EphA4. In conclusion, compound 1 has a high potential as a therapeutic agent for patients with PDAC.
  • Chemotherapy-Derived Inflammatory Responses Accelerate the Formation of Immunosuppressive Myeloid Cells in the Tissue Microenvironment of Human Pancreatic Cancer.
    Shintaro Takeuchi; Muhammad Baghdadi; Takahiro Tsuchikawa; Haruka Wada; Toru Nakamura; Hirotake Abe; Sayaka Nakanishi; Yuu Usui; Kohtaro Higuchi; Mizuna Takahashi; Kazuho Inoko; Syoki Sato; Hironobu Takano; Toshiaki Shichinohe; Ken-ichiro Seino; Satoshi Hirano
    Cancer research, 75, 13, 2629, 40, 01 Jul. 2015, [Peer-reviewed], [International Magazine]
    English, Scientific journal, Pancreatic ductal adenocarcinoma (PDAC) is the most common type of pancreatic malignancies. PDAC builds a tumor microenvironment that plays critical roles in tumor progression and metastasis. However, the relationship between chemotherapy and modulation of PDAC-induced tumor microenvironment remains poorly understood. In this study, we report a role of chemotherapy-derived inflammatory response in the enrichment of PDAC microenvironment with immunosuppressive myeloid cells. Granulocyte macrophage colony-stimulating factor (GM-CSF) is a major cytokine associated with oncogenic KRAS in PDAC cells. GM-CSF production was significantly enhanced in various PDAC cell lines or PDAC tumor tissues from patients after treatment with chemotherapy, which induced the differentiation of monocytes into myeloid-derived suppressor cells (MDSC). Furthermore, blockade of GM-CSF with monoclonal antibodies helped to restore T-cell proliferation when cocultured with monocytes stimulated with tumor supernatants. GM-CSF expression was also observed in primary tumors and correlated with poor prognosis in PDAC patients. Together, these results describe a role of GM-CSF in the modification of chemotherapy-treated PDAC microenvironment and suggest that the targeting of GM-CSF may benefit PDAC patients' refractory to current anticancer regimens by defeating MDSC-mediated immune escape.
  • Potential risk of residual cancer cells in the surgical treatment of initially unresectable pancreatic carcinoma after chemoradiotherapy.
    Hironobu Takano; Takahiro Tsuchikawa; Toru Nakamura; Keisuke Okamura; Toshiaki Shichinohe; Satoshi Hirano
    World journal of surgical oncology, 13, 209, 209, 26 Jun. 2015, [Peer-reviewed], [Lead author], [International Magazine]
    English, Scientific journal, BACKGROUND: With development of chemoradiotherapy for pancreatic carcinoma, borderline resectable or initially unresectable cases sometimes become operable after long-term intensive chemoradiotherapy. However, there is no established strategy for adjuvant surgery with respect to whether the surgical resection should be extensive or downsized accordingly with diminished disease areas following response to chemoradiotherapy. METHODS: The clinical and pathological aspects of 18 patients with initially unresectable pancreatic cancer who underwent adjuvant surgery after chemo(radio)therapy in our department from 2007 were evaluated. RESULTS: Overall survival from initial treatment was much better for patients with R0 resection than for patients with R1/2 resection. In two of three patients who had complete improvement of plexus (PL) invasion after chemo(radio)therapy, there had still remained pathological plexus invasion. It was shown that tumors did not shrink continuously from the tumor front, but parts remained discontinuously at the distal portion in the process of tumor regression by chemo(radio)therapy. CONCLUSIONS: In adjuvant surgery for patients with locally advanced pancreatic cancer, the potential risk of residual cancer in the regression area following chemoradiotherapy should be considered. Achieving R0 resection will lead to an improved prognosis, and it is necessary to consider how well the extent of resection is after a favorable response to chemoradiotherapy.
  • [A case of sigmoid colon cancer with temporary dysarthria associated with irinotecan].
    Susumu Sogabe; Satoshi Yuki; Hironobu Takano; Yoshimitsu Kobayashi; Hiroshi Nakatsumi; Takahide Sasaki; Yasuyuki Kawamoto; Hiraku Fukushima; Ichiro Iwanaga; Yasuko Uehata; Yoshito Komatsu; Masahiro Asaka
    Gan to kagaku ryoho. Cancer & chemotherapy, 38, 8, 1375, 7, Aug. 2011, [Peer-reviewed], [Domestic magazines]
    Japanese, Scientific journal, A40 -year-old woman visited our hospital with adenocaricinoma of the sigmoid colon with multiple liver metastases and ovarian metastasis. Because of a stenosis of the primary tumor, she underwent a colostomy before chemotherapy. 5-fluorouracil and irinotecan and leucovorin(FOLFIRI)was selected as first-line chemotherapy. At the start of chemotherapy, just after the end of irinotecan and leucovorin administration, the patient developed dysarthria. There were no neurological abnormalities or hematological abnormalities. The treatment was temporarily discontinued, and the dysarthria completely disappeared within 90 minutes. 5-fluorouracil was administered after the disappearance of dysarthria. Within 60 minutes of the administration of irinotecan and leucovorin at the second chemotherapy treatment, the patient developed dysarthria again. The patient had no neurological or hematological abnormalities. Magnetic resonance imaging(MRI)showed no abnormalities. The treatment was stopped and dysarthria disappeared within 60 minutes as it did the first time. At each time, no treatment for dysarthria was performed. This patient refused to continue irinotecan because of dysarthria. Therefore, chemotherapy without irinotecan was continued for the third time onward. In the previous literature, 8 cases of dysarthria caused by irinotecan were reported as a rare toxicity. In all cases, dysarthria was temporary and reversible. Because the mechanism of dysarthria is unclear, specific treatment and precaution for dysarthria is not recommended. Since dysarthria is reversible, however, irinotecan might be continued until progression.
  • [A case of sigmoid colon cancer with lymphangitis carcinomatosa successfully treated with chemotherapies including molecular targeting drugs].
    Susumu Sogabe; Satoshi Yuki; Tomofumi Takagi; Takuji Miyazaki; Hironobu Takano; Yasuyuki Kawamoto; Hiroshi Nakatsumi; Takahide Sasaki; Ichiro Iwanaga; Yasuko Uehata; Masahiro Asaka; Yoshito Komatsu
    Gan to kagaku ryoho. Cancer & chemotherapy, 37, 3, 535, 8, Mar. 2010, [Peer-reviewed], [Domestic magazines]
    Japanese, Scientific journal, A 51-year-old man was referred to our hospital with adenocarcinoma of sigmoid colon with multiple lymph node metastasis. At the time of admission, he had dyspnea, and computed tomography (CT) showed typical signs of lymphangitis carcinomatosa of the lung. Combination of mFOLFOX6 and bevacizumab was started. After start of the therapy, CT revealed an improvement in lymphangitis carcinomatosa. 8 months later, the tumor assessment became progressive disease. FOLFIRI was started as the second-line chemotherapy, but the patient did not respond. Then, dyspnea emerged again, and CT indicated the lymphangitis carcinomatosa had become worse. So as the third-line chemotherapy, combination of irinotecan and cetuximab was started. Dyspnea immediately disappeared, and CT showed an improvement of lymphangitis carcinomatosa. In the previous literature, malignant tumor cases which accompany lymphangitis carcinomatosa might always have a poor course. Our case dramatically responded to the chemotherapy including molecular targeting drug and showed a long survival. So we conclude that aggressive chemotherapy including a molecular targeting drug may be recommended in a case of colorectal cancer which accompanies lymphangitis carcinomatosa of the lung.
■ Other Activities and Achievements
  • 一般病院における多施設共同研究 傾向スコアマッチング法による胃癌に対するロボット支援下手術と腹腔鏡下手術の短期成績の比較
    京極 典憲; 海老原 裕磨; 高野 博信; 和田 秀之; 新田 健雄; 高田 実; 加藤 健太郎; 才川 大介; 山村 喜之; 七戸 俊明; 平野 聡, 日本胃癌学会総会記事, 98回, 525, 525, Mar. 2026
    (一社)日本胃癌学会, Japanese
  • 残胃癌に対するロボット支援手術 低侵襲化と標準化への可能性
    和田 秀之; 高野 博信; Saseem Poudel; 新田 健雄; 七戸 俊明; 平野 聡, 日本胃癌学会総会記事, 98回, 1077, 1077, Mar. 2026
    (一社)日本胃癌学会, Japanese
  • 食道胃接合部の神経内分泌癌と扁平上皮癌の混合型腫瘍に対して胸腔鏡併用腹腔鏡下下部食道噴門側胃切除術を施行した一例
    高橋 護; サシーム パウデル; 林 真理子; 高野 博信; 和田 秀之; 新田 健雄; 七戸 俊明; 平野 聡, 日本臨床外科学会雑誌, 87, 2, 241, 241, Feb. 2026
    日本臨床外科学会, Japanese
  • 手術待機中に腫瘍破裂を来たした孤立性線維性腫瘍(SFT)の1例
    桐山 亜斗夢; サシーム パウデル; 林 真理子; 高野 博信; 和田 秀之; 新田 健雄; 村上 壮一; 七戸 俊明; 平野 聡, 日本腹部救急医学会雑誌, 46, 2, 324, 324, Feb. 2026
    (一社)日本腹部救急医学会, Japanese
  • 手術手技 Preemptive Retropancreatic Approachによる膵上縁郭清で定型化されたロボット支援噴門側胃切除術の手術手技
    和田 秀之; 海老原 裕磨; 高野 博信; 新田 健雄; 七戸 俊明; 平野 聡, 手術, 80, 1, 111, 117, Jan. 2026
    金原出版(株), Japanese
  • 人工尿道括約筋留置後鼠径ヘルニアの1例
    丹羽 こころ; 高野 博信; 和田 秀之; 新田 健雄; 七戸 俊明; 平野 聡, 日本臨床外科学会雑誌, 87, 1, 71, 74, Jan. 2026
    日本臨床外科学会, Japanese
  • 【教室における減量・代謝改善手術-現在までの成果と今後の展望-】
    高野 博信; 海老原 裕磨; サシーム パウデル; 和田 秀之; 新田 健雄; 村上 壮一; 七戸 俊明; 平野 聡, 北海道外科雑誌, 70, 2, 90, 96, Dec. 2025
    北海道外科学会, Japanese
  • 多施設共同で胃癌に対する腹腔鏡下手術とロボット支援下手術の短期成績の比較検討
    京極 典憲; 高田 実; 海老原 裕磨; 高野 博信; 和田 秀之; 新田 健雄; 七戸 俊明; 平野 聡; 才川 大介; 山村 喜之, 北海道外科雑誌, 70, 2, 160, 161, Dec. 2025
    北海道外科学会, Japanese
  • 重複下大静脈を伴う食道胃接合部癌に対するロボット支援下大動脈周囲リンパ節郭清術の経験
    和田 秀之; 高野 博信; Saseem Poudel; 新田 健雄; 七戸 俊明; 平野 聡, 北海道外科雑誌, 70, 2, 161, 161, Dec. 2025
    北海道外科学会, Japanese
  • 局所進行膵体部癌に対する脾温存DP-CAR(spleen preserving DP-CAR:SPDP-CAR)の短期成績
    和田 雅孝; 武内 慎太郎; 田中 公貴; 松井 あや; 中西 喜嗣; 浅野 賢道; 野路 武寛; サシーム パウデル; 宮崎 大; 高野 博信; 和田 秀之; 新田 健雄; 村上 壮一; 七戸 俊明; 平野 聡, 北海道外科雑誌, 70, 2, 180, 180, Dec. 2025
    北海道外科学会, Japanese
  • 近赤外線蛍光分光システムLumifinderTMとインドシアニングリーン(ICG)を用いた食道切除術における胃管血流の定量評価
    新田 健雄; 海老原 裕磨; 高野 博信; 和田 秀之; 七戸 俊明; 平野 聡, 北海道医学雑誌, 100, 2, 106, 106, Nov. 2025
    北海道医学会, Japanese
  • Interval appendectomy後にAppendiceal Goblet cell Adenocarcinoma(AGCA)の診断となり追加切除施行した1例
    窪田 武哲; 山田 秀久; 成田 翔; 植村 慧子; 櫛引 敏寛; 高野 博信; 岩村 八千代; 三浦 巧; 市之川 一臣; 道免 寛充, 日本臨床外科学会雑誌, 86, 10, 1415, 1415, Oct. 2025
    日本臨床外科学会, Japanese
  • 乳癌症例に対するCDK4/6阻害剤の使用経験
    市之川 一臣; 成田 翔; 窪田 武哲; 植村 慧子; 櫛引 敏寛; 高野 博信; 三浦 巧; 道免 寛充; 岩村 八千代; 山田 秀久, 日本臨床外科学会雑誌, 86, 10, 1421, 1421, Oct. 2025
    日本臨床外科学会, Japanese
  • 低侵襲手術時代における若手教育と開胸手術教育 遠隔ロボット手術の時代 若手外科医教育の新たな可能性 遠隔手術支援によるロボット食道切除術のカダバースタディー
    海老原 裕磨; 高野 博信; 諸橋 一; 沖 英次; 七戸 俊明; 袴田 健一; 平野 聡; 池田 徳彦; 森 正樹, 日本胸部外科学会定期学術集会, 78回, CDWS1, 1, Oct. 2025
    (一社)日本胸部外科学会, Japanese
  • Siewert II型食道胃接合部腺癌に対する腹腔鏡併用胸腔鏡下左胸腔アプローチ(MALTA)の短期・中期成績の検討
    新田 健雄; 七戸 俊明; 高野 博信; パウデル サシーム; 和田 秀之; 村上 壮一; 平野 聡, 日本胸部外科学会定期学術集会, 78回, EMO8, 2, Oct. 2025
    (一社)日本胸部外科学会, Japanese
  • 当教室における腹腔鏡下スリーブ状胃切除術の手術成績とMASLDとの関連について
    高野 博信; 海老原 裕磨; Saseem Paudel; 和田 秀之; 新田 健雄; 七戸 俊明; 平野 聡, 肥満研究, 31, 合同学術集会抄録集, 469, 469, Oct. 2025
    (一社)日本肥満学会, Japanese
  • 手術手技 腹腔鏡下噴門側胃切除術の再建法の工夫 後壁斜め吻合(Oblique Jejunogastrostomy)法
    高野 博信; 和田 秀之; 新田 健雄; 海老原 裕磨; 七戸 俊明; 平野 聡, 手術, 79, 9, 1431, 1438, Aug. 2025
    金原出版(株), Japanese
  • 当科における食道良性腫瘍に対する手術治療成績
    高橋 護; 新田 健雄; 林 真理子; パウデル サシーム; 高野 博信; 和田 秀之; 七戸 俊明; 平野 聡, 日本消化器病学会北海道支部例会・日本消化器内視鏡学会北海道支部例会プログラム・抄録集, 137回・131回, 36, 36, Aug. 2025
    日本消化器病学会-北海道支部, Japanese
  • 新規内視鏡用蛍光スペクトル測定装置「Lumifinder」を用いた術中腫瘍同定法(Detecting fluorescent marking clip with a novel laparoscopic fluorescence detection system)
    海老原 裕磨; 上村 志臣; 高野 博信; 和田 秀之; 新田 健雄; 小西 和哉; 七戸 俊明; 平野 聡, 日本消化器外科学会総会, 80回, 747, 747, Jul. 2025
    (一社)日本消化器外科学会, Japanese
  • 当教室における十二指腸腫瘍に対するDLECSの経験と工夫(Our experience and innovations in DLECS for duodenal tumors)
    高野 博信; 海老原 裕磨; 和田 秀之; 新田 健雄; 七戸 俊明; 平野 聡, 日本消化器外科学会総会, 80回, 3025, 3025, Jul. 2025
    (一社)日本消化器外科学会, Japanese
  • 術前治療を受けた食道癌根治切除後のGNRIの臨床的意義
    新田 健雄; 七戸 俊明; 高野 博信; 和田 秀之; 海老原 裕磨; 平野 聡, 日本食道学会学術集会プログラム・抄録集, 79回, 164, 164, Jun. 2025
    (NPO)日本食道学会, Japanese
  • COVID-19感染合併の食道胃接合部癌術後縫合不全に対するT-tube奏功例
    黒滝 拓磨; 海老原 裕磨; 板垣 有紀; 林 真理子; 高野 博信; 和田 秀之; 新田 健雄; 七戸 俊明; 平野 聡, 日本食道学会学術集会プログラム・抄録集, 79回, 223, 223, Jun. 2025
    (NPO)日本食道学会, Japanese
  • 当院における高齢者食道癌患者に対する外科治療の短期成績
    和田 秀之; 七戸 俊明; 海老原 裕麿; 高野 博信; 新田 健雄; 平野 聡, 日本食道学会学術集会プログラム・抄録集, 79回, 294, 294, Jun. 2025
    (NPO)日本食道学会, Japanese
  • 高齢者(65歳以上)の食道癌根治切除例におけるGNRIの臨床的意義
    新田 健雄; 七戸 俊明; 高野 博信; 和田 秀之; 海老原 裕磨; 平野 聡, 日本外科学会定期学術集会抄録集, 125回, PS, 6, Apr. 2025
    (一社)日本外科学会, Japanese
  • 術前GISTと診断された食道粘膜下腫瘍に対し左胸腔・腹腔同時アプローチ(MALTA)にて切除した1例
    桐山 亜斗夢; 和田 秀之; 林 真理子; 高野 博信; 新田 健雄; 海老原 裕磨; 七戸 俊明; 平野 聡, 日本消化器病学会北海道支部例会・日本消化器内視鏡学会北海道支部例会プログラム・抄録集, 136回・130回, 53, 53, Mar. 2025
    日本消化器病学会-北海道支部, Japanese
  • BRCA遺伝子変異陽性,再発男性乳癌にOlaparibを投与した1例
    市之川 一臣; 成田 翔; 窪田 武哲; 植村 慧子; 櫛引 敏寛; 高野 博信; 三浦 巧; 道免 寛充; 岩村 八千代; 山田 秀久, 北海道外科雑誌, 69, 2, 174, 174, Dec. 2024
    北海道外科学会, Japanese
  • OncotypeDx検査を誰にどのように勧めるか
    岩村 八千代; 窪田 武哲; 植村 慧子; 三浦 巧; 櫛引 敏寛; 高野 博信; 市之川 一臣; 山田 秀久; 成田 翔; 道免 寛充; 高桑 康成; 敷島 裕之, 北海道外科雑誌, 69, 2, 177, 178, Dec. 2024
    北海道外科学会, Japanese
  • 当教室における腹腔鏡下噴門側胃切除術の再建法の工夫 後壁斜め吻合(Oblique Jejunogastrostomy)法
    高野 博信; 海老原 裕磨; 林 真理子; 阿部 紘丈; 和田 秀之; 新田 健雄; 七戸 俊明; 平野 聡, 日本内視鏡外科学会雑誌, 29, 7, O13, 2, Dec. 2024
    (一社)日本内視鏡外科学会, Japanese
  • 当院における若手外科医へのロボット支援内視鏡手術導入の工夫
    窪田 武哲; 山田 秀久; 成田 翔; 植村 慧子; 櫛引 敏寛; 高野 博信; 三浦 巧; 道免 寛充, 日本内視鏡外科学会雑誌, 29, 7, MO197, 3, Dec. 2024
    (一社)日本内視鏡外科学会, Japanese
  • 腹腔鏡下噴門側胃切除術後に生じた横隔膜ヘルニア嵌頓の1手術例
    成田 翔; 道免 寛充; 林 真理子; 櫛引 敏寛; 高野 博信; 三浦 巧; 市之川 一臣; 山田 秀久, 日本臨床外科学会雑誌, 85, 増刊, S269, S269, Oct. 2024
    日本臨床外科学会, Japanese
  • 国産手術支援ロボットhinotoriTMにおけるダブルコックピットを用いた遠隔操作によるロボット食道手術支援のカダバースタディー
    海老原 裕磨; 高野 博信; 倉島 庸; 村上 壮一; 諸橋 一; 沖 英次; 七戸 俊明; 袴田 健一; 平野 聡; 森 正樹, 日本消化器病学会北海道支部例会・日本消化器内視鏡学会北海道支部例会プログラム・抄録集, 135回・129回, 27, 27, Aug. 2024
    日本消化器病学会-北海道支部, Japanese
  • トラスツズマブ デルクスカンを使用した転移性乳癌の12例(第2報)
    市之川 一臣; 竹野 巨樹; 窪田 武哲; 櫛引 敏寛; 高野 博信; 道免 寛充; 岩村 八千代; 山田 秀久, 日本乳癌学会総会プログラム抄録集, 32回, 361, 361, Jul. 2024
    (一社)日本乳癌学会, Japanese
  • 多発病変に対するロボット支援腹腔鏡下大腸切除術の検討
    山田 秀久; 道免 寛充; 高野 博信; 窪田 武浩, 日本消化器外科学会総会, 79回, 813, 813, Jul. 2024
    (一社)日本消化器外科学会, Japanese
  • 当院におけるロボット支援下右側結腸切除術23例の短期治療成績
    櫛引 敏寛; 岩村 八千代; 大塚 将平; 高野 博信; 道免 寛充; 市之川 一臣; 山田 秀久, 日本外科学会定期学術集会抄録集, 124回, PS, 3, Apr. 2024
    (一社)日本外科学会, Japanese
  • 鼠径部ヘルニアに対するTEP法の検討
    山田 秀久; 市之川 一臣; 道免 寛充; 高野 博信; 櫛引 敏寛, 日本外科学会定期学術集会抄録集, 124回, PS, 3, Apr. 2024
    (一社)日本外科学会, Japanese
  • 安全技術認定に通るユニポートVATSとは Uniportalで胸腔鏡安全技術認定制度に合格するコツと当院における若手医師の修練法
    道免 寛充; 竹野 巨樹; 窪田 武哲; 櫛引 敏寛; 高野 博信; 市之川 一臣; 岩村 八千代; 山田 秀久, 日本呼吸器外科学会雑誌, 38, 3, WS5, 2, Apr. 2024
    (一社)日本呼吸器外科学会, Japanese
  • 5-port RATSの利点を損なわないreduced port RATSの確立に向けた取り組み
    道免 寛充; 竹野 巨樹; 窪田 武哲; 櫛引 敏寛; 高野 博信; 市之川 一臣; 岩村 八千代; 山田 秀久, 日本呼吸器外科学会雑誌, 38, 3, O26, 2, Apr. 2024
    (一社)日本呼吸器外科学会, Japanese
  • 医師の働き方改革制度開始を念頭に置いた臨床工学技士の手術参加
    道免 寛充; 竹野 巨樹; 窪田 武哲; 櫛引 敏寛; 高野 博信; 市之川 一臣; 岩村 八千代; 山田 秀久, 日本呼吸器外科学会雑誌, 38, 3, O30, 1, Apr. 2024
    (一社)日本呼吸器外科学会, Japanese
  • 肺切除中にaccidentalに片肺換気が不能になり両肺換気のまま肺切除を遂行した3例
    道免 寛充; 竹野 巨樹; 窪田 武哲; 櫛引 敏寛; 高野 博信; 市之川 一臣; 岩村 八千代; 山田 秀久, 日本呼吸器外科学会雑誌, 38, 3, O33, 5, Apr. 2024
    (一社)日本呼吸器外科学会, Japanese
  • 同時性重複癌を有する高齢者に生じた肋骨原発孤立性形質細胞腫の顕微鏡的断端陽性に対する考え方
    道免 寛充; 竹野 巨樹; 窪田 武哲; 櫛引 敏寛; 高野 博信; 市之川 一臣; 岩村 八千代; 山田 秀久, 日本呼吸器外科学会雑誌, 38, 3, O65, 7, Apr. 2024
    (一社)日本呼吸器外科学会, Japanese
  • 肺アスペルギルス症における肺嚢胞開窓と遊離脂肪織弁充填の経験
    竹野 巨樹; 道免 寛充; 窪田 武哲; 櫛引 敏寛; 高野 博信; 岩村 八千代; 市之川 一臣; 山田 秀久, 日本呼吸器外科学会雑誌, 38, 3, MO46, 6, Apr. 2024
    (一社)日本呼吸器外科学会, Japanese
  • 腹腔鏡下噴門側胃切除術後に生じた食道裂孔ヘルニア嵌頓の1例
    林 真理子; 道免 寛充; 大塚 将平; 櫛引 敏寛; 高野 博信; 市之川 一臣; 岩村 八千代; 山田 秀久, 日本臨床外科学会雑誌, 85, 3, 427, 427, Mar. 2024
    日本臨床外科学会, Japanese
  • 若手医師のU-VATSの修練
    大塚 将平; 道免 寛充; 櫛引 敏寛; 高野 博信; 市之川 一臣; 岩村 八千代; 山田 秀久, 日本臨床外科学会雑誌, 85, 3, 428, 428, Mar. 2024
    日本臨床外科学会, Japanese
  • 婦人科疾患,処置の関与が濃厚に疑われた汎発性腹膜炎の2例 女性の急性腹症の鑑別には,婦人科系の問診が重要である
    須藤 ゆきほ; 小野寺 学; 長嶋 一哲; 川岸 直樹; 松本 美桜; 太宰 昌佳; 加藤 総介; 窪田 武哲; 櫛引 敏寛; 高野 博信; 山田 秀久, 日本消化器病学会北海道支部例会・日本消化器内視鏡学会北海道支部例会プログラム・抄録集, 134回・128回, 75, 75, Mar. 2024
    日本消化器病学会-北海道支部, Japanese
  • 先天性アンチトロンビン欠乏症患者に対する前縦隔腫瘍手術の周術期管理
    道免 寛充; 八木 優樹; 田路 悠太; 林 真理子; 高野 博信; 市之川 一臣; 岩村 八千代; 山田 秀久, 日本臨床外科学会雑誌, 85, 2, 305, 305, Feb. 2024
    日本臨床外科学会, Japanese
  • 単孔式ロボット支援下で施行した心膜憩室手術
    道免 寛充; 八木 優樹; 田路 悠太; 林 真理子; 高野 博信; 市之川 一臣; 岩村 八千代; 山田 秀久, 日本臨床外科学会雑誌, 85, 2, 306, 306, Feb. 2024
    日本臨床外科学会, Japanese
  • 腹腔鏡下にヘルニア修復術を施行したCABG後の横隔膜ヘルニア嵌頓の1例
    高野 博信; 大塚 将平; 窪田 武哲; 櫛引 敏寛; 道免 寛充; 岩村 八千代; 市之川 一臣; 山田 秀久, 日本腹部救急医学会雑誌, 44, 2, 389, 389, Feb. 2024
    (一社)日本腹部救急医学会, Japanese
  • 炎症性乳癌が疑われたLupus Mastitisの1例
    岩村 八千代; 大塚 将平; 櫛引 敏寛; 高野 博信; 道免 寛充; 市之川 一臣; 山田 秀久; 坊垣 幸; 高桑 康成, 北海道外科雑誌, 68, 2, 166, 166, Dec. 2023
    北海道外科学会, Japanese
  • 血中微量元素を用いたがんリスク診断法で診断された乳癌の1例
    市之川 一臣; 大塚 将平; 櫛引 敏寛; 高野 博信; 道免 寛充; 岩村 八千代; 山田 秀久, 北海道外科雑誌, 68, 2, 170, 171, Dec. 2023
    北海道外科学会, Japanese
  • 当院におけるロボット支援下右側結腸切除術の導入と短期治療成績
    櫛引 敏寛; 山田 秀久; 道免 寛充; 高野 博信; 大塚 将平, 日本内視鏡外科学会雑誌, 28, 7, 519, 519, Dec. 2023
    (一社)日本内視鏡外科学会, Japanese
  • ロボット支援肺切除における葉間作成の工夫
    道免 寛充; 大塚 将平; 櫛引 敏寛; 高野 博信; 山田 秀久, 日本内視鏡外科学会雑誌, 28, 7, 1238, 1238, Dec. 2023
    (一社)日本内視鏡外科学会, Japanese
  • ロボット支援直腸癌手術の長期成績 ロボット支援下直腸切除術の治療成績
    山田 秀久; 道免 寛充; 高野 博信; 櫛引 敏寛, 日本内視鏡外科学会雑誌, 28, 7, 1378, 1378, Dec. 2023
    (一社)日本内視鏡外科学会, Japanese
  • 呼吸器外科胸腔鏡安全技術認定制度の現状と課題 不合格と合格、両方を経験したからこそわかる単孔式VATS手技のポイント
    道免 寛充; 大塚 将平; 櫛引 敏寛; 高野 博信; 山田 秀久, 日本内視鏡外科学会雑誌, 28, 7, 1406, 1406, Dec. 2023
    (一社)日本内視鏡外科学会, Japanese
  • Cerfolio's method変法におけるfissureless lobectomyの特徴
    道免 寛充; 大塚 将平; 櫛引 敏寛; 高野 博信; 山田 秀久, 日本内視鏡外科学会雑誌, 28, 7, 1671, 1671, Dec. 2023
    (一社)日本内視鏡外科学会, Japanese
  • 側胸部アプローチによる単孔式ロボット支援縦隔手術
    道免 寛充; 大塚 将平; 櫛引 敏寛; 高野 博信; 山田 秀久, 日本内視鏡外科学会雑誌, 28, 7, 2281, 2281, Dec. 2023
    (一社)日本内視鏡外科学会, Japanese
  • 結腸憩室炎に対する低侵襲手術 大腸憩室炎に対する低侵襲手術治療成績
    山田 秀久; 道免 寛充; 高野 博信; 櫛引 敏寛, 日本内視鏡外科学会雑誌, 28, 7, 3227, 3227, Dec. 2023
    (一社)日本内視鏡外科学会, Japanese
  • ロボット支援呼吸器外科手術におけるclippingとエネルギーデバイスを用いた肺動脈の処理
    道免 寛充; 大塚 将平; 櫛引 敏寛; 高野 博信; 市之川 一臣; 岩村 八千代; 山田 秀久, 日本胸部外科学会定期学術集会, 76回, LP1, 7, Oct. 2023
    (一社)日本胸部外科学会, Japanese
  • 腹壁瘢痕ヘルニアのベストプラクティス 腹壁瘢痕ヘルニアに対する手術治療成績
    高野 博信; 市之川 一臣; 道免 寛充; 櫛引 敏寛, 日本臨床外科学会雑誌, 84, 増刊, S193, S193, Oct. 2023
    日本臨床外科学会, Japanese
  • 若年外傷性膵IIIb型損傷に対して非手術療法が有効であった1例
    高野 博信; 板垣 有紀; 山本 和幸; 西上 耕平; 福永 亮朗; 市村 龍之助; 真名瀬 博人; 平野 聡, 日本外傷学会雑誌, 37, 3, 302, 306, Jul. 2023
    (一社)日本外傷学会, Japanese
  • 反復する嚢胞内出血に対して膵頭十二指腸切除術を施行した膵IPMAの1例
    高野 博信; 田路 悠太; 林 真理子; 八木 優樹; 岩村 八千代; 道免 寛充; 市之川 一臣; 山田 秀久, 膵臓, 38, 3, A512, A512, Jul. 2023
    (一社)日本膵臓学会, Japanese
  • 急性胆嚢炎に対する治療成績
    山田 秀久; 道免 寛充; 高野 博信; 林 真理子, 日本消化器外科学会総会, 78回, P086, 3, Jul. 2023
    (一社)日本消化器外科学会, Japanese
  • トラスツズマブデルクスカンを使用したHER2陽性転移性乳癌の5例
    市之川 一臣; 田路 悠太; 八木 優樹; 林 真理子; 高野 博信; 道免 寛充; 岩村 八千代; 山田 秀久, 日本乳癌学会総会プログラム抄録集, 31回, 262, 262, Jun. 2023
    (一社)日本乳癌学会, Japanese
  • 単孔式ロボット支援縦隔手術の初期導入成績
    道免 寛充; 八木 優樹; 田路 悠太; 林 真理子; 高野 博信; 市之川 一臣; 岩村 八千代; 山田 秀久, 日本呼吸器外科学会雑誌, 37, 3, O34, 2, Jun. 2023
    (一社)日本呼吸器外科学会, Japanese
  • 腫瘍径1.0cm以下の微小病変に対する肺区域切除を試みて病理学的にリンパ節転移陽性と診断された2例の経験
    道免 寛充; 八木 優樹; 田路 悠太; 林 真理子; 高野 博信; 市之川 一臣; 岩村 八千代; 山田 秀久, 日本呼吸器外科学会雑誌, 37, 3, P1, 3, Jun. 2023
    (一社)日本呼吸器外科学会, Japanese
  • 先天性アンチトロンビン欠乏症患者の前縦隔良性嚢胞に対して施行した単孔式ロボット手術
    道免 寛充; 高野 博信; 市之川 一臣; 岩村 八千代; 山田 秀久, 小切開・鏡視外科学会雑誌, 14, 1, 45, 45, May 2023
    (NPO)小切開・鏡視外科学会, Japanese
  • ロボット支援呼吸器外科手術における最背側創部出血の予防法
    道免 寛充; 八木 優樹; 田路 悠太; 林 真理子; 高野 博信; 市之川 一臣; 岩村 八千代; 山田 秀久, 日本外科学会定期学術集会抄録集, 123回, DP, 5, Apr. 2023
    (一社)日本外科学会, Japanese
  • ロボット支援呼吸器外科手術をsmoothに遂行する方法
    道免 寛充; 八木 優樹; 田路 悠太; 林 真理子; 高野 博信; 市之川 一臣; 岩村 八千代; 山田 秀久, 日本外科学会定期学術集会抄録集, 123回, DP, 8, Apr. 2023
    (一社)日本外科学会, Japanese
  • 直腸癌ロボット支援手術の習熟度に関する検討
    山田 秀久; 市之川 一臣; 道免 寛充; 高野 博信; 林 真理子; 八木 優樹; 田路 悠人, 日本外科学会定期学術集会抄録集, 123回, DP, 1, Apr. 2023
    (一社)日本外科学会, Japanese
  • 困難症例に対する呼吸器外科ロボット支援手術:手技の工夫と成績 ロボット支援下に施行した隣接臓器合併切除の経験 横隔膜、胸壁
    道免 寛充; 八木 優樹; 樋田 泰浩; 林 真理子; 高野 博信; 山田 秀久, 日本内視鏡外科学会雑誌, 27, 7, 447, 447, Dec. 2022
    (一社)日本内視鏡外科学会, Japanese
  • 困難症例に対する呼吸器外科ロボット支援手術:手技の工夫と成績 リンパ節固着症例に対してロボット支援下に行うTemporary Segmental Bronchus Incision Techniqueの要点
    道免 寛充; 八木 優樹; 樋田 泰浩; 林 真理子; 高野 博信; 山田 秀久, 日本内視鏡外科学会雑誌, 27, 7, 449, 449, Dec. 2022
    (一社)日本内視鏡外科学会, Japanese
  • ロボット支援肺癌手術におけるリンパ節郭清のラーニングカーブ
    道免 寛充; 八木 優樹; 樋田 泰浩; 林 真理子; 高野 博信; 山田 秀久, 日本内視鏡外科学会雑誌, 27, 7, 2566, 2566, Dec. 2022
    (一社)日本内視鏡外科学会, Japanese
  • 急性膿胸の病悩期間の長さは術中/術後経過に影響を及ぼす
    八木 優樹; 道免 寛充; 樋田 泰浩; 林 真理子; 高野 博信; 山田 秀久, 日本内視鏡外科学会雑誌, 27, 7, 2938, 2938, Dec. 2022
    (一社)日本内視鏡外科学会, Japanese
  • 肺手術におけるindocyanine greenの使い道
    道免 寛充; 八木 優樹; 田路 悠太; 林 真理子; 高野 博信; 市之川 一臣; 岩村 八千代; 山田 秀久, 日本臨床外科学会雑誌, 83, 12, 2118, 2118, Dec. 2022
    日本臨床外科学会, Japanese
  • 当院のHBOC症例の臨床像とサーベイランス
    岩村 八千代; 田路 悠太; 八木 優樹; 林 真理子; 高野 博信; 道免 寛充; 市之川 一臣; 山田 秀久; 高桑 康成; 敷島 裕之, 北海道外科雑誌, 67, 2, 160, 160, Dec. 2022
    北海道外科学会, Japanese
  • 血中微量元素を用いたがんリスク診断法で診断された乳癌の1例
    市之川 一臣; 田路 悠太; 八木 優樹; 林 真理子; 高野 博信; 道免 寛充; 岩村 八千代; 山田 秀久, 北海道外科雑誌, 67, 2, 169, 169, Dec. 2022
    北海道外科学会, Japanese
  • 低異型度虫垂粘液性腫瘍
    板垣 有紀; 高野 博信; 山本 和幸; 西上 耕平; 福永 亮朗; 市村 龍之助; 真名瀬 博人, 日本臨床外科学会雑誌, 83, 10, 1844, 1844, Oct. 2022
    日本臨床外科学会, Japanese
  • cT4肺癌に対するロボット支援下手術
    道免 寛充; 樋田 泰浩; 八木 優樹; 田路 悠太; 林 真理子; 高野 博信; 市之川 一臣; 岩村 八千代; 山田 秀久, 日本胸部外科学会定期学術集会, 75回, LOP9, 3, Oct. 2022
    (一社)日本胸部外科学会, Japanese
  • 外傷性膵損傷の2例の経験
    高野 博信; 板垣 有紀; 山本 和幸; 西上 耕平; 高橋 徹; 福永 亮朗; 市村 龍之助; 真名瀬 博人, 日本外傷学会雑誌, 36, 2, 210, 210, Jun. 2022
    (一社)日本外傷学会, Japanese
  • 【心臓・呼吸器:単孔式胸腔鏡下手術、ロボット支援手術における血管処理の実際】当科におけるロボット支援肺手術と単孔式胸腔鏡下手術の血管処理法
    道免 寛充; 樋田 泰浩; 田路 悠太; 八木 優樹; 林 真理子; 高野 博信; 市之川 一臣; 岩村 八千代; 山田 秀久, 小切開・鏡視外科学会雑誌, 13, 1, 39, 39, Jun. 2022
    (NPO)小切開・鏡視外科学会, Japanese
  • 病棟看護師を対象とした肥満症手術動画による学習会の効果
    小野寺 ゆい; 田代 智都; 宮崎 真弓; 長谷川 浩美; 高野 博信; 山本 和幸, 肥満研究, 27, Suppl., 309, 309, Mar. 2022
    (一社)日本肥満学会, Japanese
  • 腹腔動脈血栓症・脾梗塞の1例
    市村 龍之助; 板垣 有紀; 高野 博信; 山本 和幸; 西上 耕平; 高橋 徹; 真名瀬 博人, 日本臨床外科学会雑誌, 82, 10, 1939, 1940, Oct. 2021
    日本臨床外科学会, Japanese
  • Bariatric surgery for Obese-end stage REnAl disease by laparoscopic Sleeve gastrectomy followed by SMAP BOREASS手術
    山下 智久; 山本 和幸; 高野 博信; 平 康二; 海老原 裕磨; 倉 麻里香; 我孫子 亜津子; 鈴木 陶磨; 松田 正大; 西沢 慶太郎; 小林 広学, 日本透析医学会雑誌, 54, Suppl.1, 362, 362, May 2021
    (一社)日本透析医学会, Japanese
  • 血小板無力症を伴う上行結腸癌に対し腹腔鏡下右半結腸切除術を施行した1例
    窪田 武哲; 山本 和幸; 高野 博信; 西上 耕平; 市村 龍之助; 真名瀬 博人; 平 康二, 日本臨床外科学会雑誌, 81, 4, 796, 796, Apr. 2020
    日本臨床外科学会, Japanese
  • 外傷性腹壁ヘルニアに対して待機的に腹腔鏡下ヘルニア修復術を施行した1例
    高野 博信; 宮坂 大介; 蔵前 太郎; 市村 龍之助; 真名瀬 博人; 平 康二, Japanese Journal of Acute Care Surgery, 9, 2, 258, 262, Jan. 2020
    (一社)日本Acute Care Surgery学会, Japanese
  • 食道内誤飲した総義歯を胃内に移動させたのち腹腔鏡下で摘出した1例
    東嶋 宏泰; 真名瀬 博人; 平 康二; 市村 龍之助; 蔵前 太郎; 西上 耕平; 高野 博信, 日本臨床外科学会雑誌, 80, 12, 2300, 2300, Dec. 2019
    日本臨床外科学会, Japanese
  • 血小板無力症を伴う上行結腸癌に対し腹腔鏡下右半結腸切除術を施行した1例
    山本 和幸; 窪田 武哲; 高野 博信; 西上 耕平; 市村 龍之助; 真名瀬 博人; 平 康二, Japanese Journal of Acute Care Surgery, 9, 1, 203, 203, Oct. 2019
    (一社)日本Acute Care Surgery学会, Japanese
  • 地方病院における腹腔鏡下鼠径ヘルニア根治術(TEP法)の導入
    窪田 武哲; 山本 和幸; 高野 博信; 西上 耕平; 市村 龍之助; 真名瀬 博人; 平 康二, 日本臨床外科学会雑誌, 80, 増刊, 631, 631, Oct. 2019
    日本臨床外科学会, Japanese
  • 急性心筋梗塞による心肺停止で蘇生後腹腔内出血を来した1例
    東嶋 宏泰; 高野 博信; 西上 耕平; 蔵前 太郎; 市村 龍之助; 真名瀬 博人; 平 康二, 日本臨床外科学会雑誌, 80, 5, 1029, 1029, May 2019
    日本臨床外科学会, Japanese
  • 術前診断しえた十二指腸憩室内結石による後腹膜穿通の1例
    東嶋 宏泰; 平 康二; 真名瀬 博人; 市村 龍之助; 蔵前 太郎; 西上 耕平; 高野 博信, 日本臨床外科学会雑誌, 80, 2, 445, 445, Feb. 2019
    日本臨床外科学会, Japanese
  • 腹腔鏡下に診断・治療した鼠径部interparietal herniaの1例
    市村 龍之助; 平 康二; 真名瀬 博人; 蔵前 太郎; 高野 博信, 日本臨床外科学会雑誌, 79, 6, 1331, 1331, Jun. 2018
    日本臨床外科学会, Japanese
  • Hem-o-lokを用いた虫垂根部処理による腹腔鏡下虫垂切除術の経験
    高野 博信; 宮坂 大介; 蔵前 太郎; 市村 龍之助; 真名瀬 博人; 平 康二, 日本内視鏡外科学会雑誌, 22, 7, EP013, 05, Dec. 2017
    (一社)日本内視鏡外科学会, Japanese
  • 誤嚥エピソードのない腹腔内針状異物の腹腔鏡下摘出の1例
    東嶋 宏泰; 平 康二; 真名瀬 博人; 市村 龍之助; 蔵前 太郎; 高野 博信, 日本内視鏡外科学会雑誌, 22, 7, EP166, 02, Dec. 2017
    (一社)日本内視鏡外科学会, Japanese
  • Paclitaxel+Bevacizumab療法を施行した乳癌癌性胸膜炎の1例
    宮坂 大介; 高野 博信; 蔵前 太郎; 真名瀬 博人; 平 康二, 臨牀と研究, 94, 9, 1155, 1158, Sep. 2017
    大道学館出版部, Japanese
  • 交通事故を契機に発症した巨大外傷性腹壁ヘルニアに対して腹腔鏡下ヘルニア修復術を施行した1例
    高野 博信; 宮坂 大介; 蔵前 太郎; 市村 龍之助; 真名瀬 博人; 平 康二, Japanese Journal of Acute Care Surgery, 7, 1, 211, 211, Sep. 2017
    (一社)日本Acute Care Surgery学会, Japanese
  • 異時性に腸管壊死をきたした腸管嚢胞状気腫症の一例
    蔵前 太郎; 高野 博信; 市村 龍之介; 真名瀬 博人; 平 康二, Japanese Journal of Acute Care Surgery, 7, 1, 239, 239, Sep. 2017
    (一社)日本Acute Care Surgery学会, Japanese
  • 経胸的胃刺創の1手術例
    東嶋 宏泰; 高野 博信; 宮坂 大介; 蔵前 太郎; 真名瀬 博人; 平 康二, 北海道外科雑誌, 61, 2, 186, 186, Dec. 2016
    北海道外科学会, Japanese
  • Bevacizumab+Paclitaxel療法が奏功した乳癌癌性胸膜炎の1例
    宮坂 大介; 高野 博信; 蔵前 太郎; 真名瀬 博人; 平 康二, 北海道外科雑誌, 61, 2, 195, 196, Dec. 2016
    北海道外科学会, Japanese
  • 回腸導管増設後の傍ストーマヘルニアに対し、腹腔鏡下ヘルニア修復術を施行した1例
    宮坂 大介; 武内 優太; 高野 博信; 安孫子 剛大; 真名瀬 博人; 平 康二, 日本消化器外科学会雑誌, 49, Suppl.2, 233, 233, Nov. 2016
    (一社)日本消化器外科学会, Japanese
  • 急性虫垂炎を契機に上腸間膜静脈血栓症を発症した1例
    武内 優太; 平 康二; 真名瀬 博人; 宮坂 大介; 安孫子 剛大; 高野 博信, 日本臨床外科学会雑誌, 77, 9, 2330, 2330, Sep. 2016
    日本臨床外科学会, Japanese
  • 増殖型レトロウイルスシステムを用いた膵癌に対するプロドラッグ活性化遺伝子治療
    猪子 和穂; 平岡 圭; 稲垣 亮仁; 高橋 瑞奈; 櫛引 敏寛; 本谷 康二; 高野 博信; 佐藤 彰記; 中村 透; 土川 貴裕; 七戸 俊明; Gruber Harry E.; Jolly Douglas J.; Kasahara Noriyuki; 平野 聡, 日本外科学会定期学術集会抄録集, 116回, YT, 4, Apr. 2016
    (一社)日本外科学会, Japanese
  • 肝胆膵癌領域における次世代外科治療の展望 膵癌局所の微小環境制御による化学療法抵抗性の克服を目指して
    武内 慎太郎; 土川 貴裕; 中村 透; 猪子 和穂; 高橋 瑞奈; 佐藤 彰記; 高野 博信; 七戸 俊明; 平野 聡, 日本外科学会定期学術集会抄録集, 116回, WS, 7, Apr. 2016
    (一社)日本外科学会, Japanese
  • 上部進行胃癌に対する完全腹腔鏡下胃全摘術D2郭清(TLTGS)
    海老原 裕磨; 高野 博信; 倉島 庸; 村上 壮一; 田本 英司; 中村 透; 岡村 圭祐; 七戸 俊明; 平野 聡, 日本胃癌学会総会記事, 87回, 233, 233, Mar. 2015
    (一社)日本胃癌学会, Japanese
  • 腹腔鏡下胃全摘術におけるlinear staplerを用いた食道空腸吻合 連続86例の手術成績
    高野 博信, 日本胃癌学会総会記事, 87回, 269, 269, Mar. 2015
    (一社)日本胃癌学会, Japanese
  • 腹腔鏡下膵体尾部切除を施行した膵ガストリノーマの1例
    横山 啓介; 海老原 裕磨; サシーム・パウデル; 野口 美紗; 高野 博信; 芦立 嘉智; 佐藤 暢人; 蔵前 太郎; 松村 祥幸; 村上 壮一; 田本 英司; 倉島 庸; 中村 透; 松本 譲; 土川 貴裕; 田中 栄一; 七戸 俊明; 平野 聡, 日本臨床外科学会雑誌, 75, 9, 2642, 2642, Sep. 2014
    日本臨床外科学会, Japanese
  • 消化器癌に対する免疫療法 進行・再発消化器癌に対する新規癌ワクチンCHP-MAGE-A4の臨床応用と特異的免疫反応の解析
    土川 貴裕; 中村 透; 武内 慎太郎; 桑谷 俊彦; 高野 博信; 七戸 俊明; 平野 聡, 日本消化器外科学会総会, 69回, SY, 3, Jul. 2014
    (一社)日本消化器外科学会, Japanese
  • 診断時切除不能膵癌に対するadjuvant surgeryにおける切除範囲の検討
    高野 博信; 中村 透; 佐藤 暢人; 倉島 庸; 海老原 裕磨; 村上 壮一; 田本 英司; 松本 譲; 土川 貴裕; 岡村 圭祐; 七戸 俊明; 平野 聡, 膵臓, 29, 3, 638, 638, Jun. 2014
    (一社)日本膵臓学会, Japanese
  • 膵癌化学放射線療法は膵癌局所の微小免疫環境を増強する
    土川 貴裕; 武内 慎太郎; 佐藤 彰記; 高野 博信; 猪子 和穂; 高橋 瑞奈; 中村 透; 七戸 俊明; 平野 聡, 日本がん免疫学会総会プログラム・抄録集, 18回, 150, 150, Jun. 2014
    (一社)日本がん免疫学会, Japanese
  • 完全腹腔鏡下に胆管切除・胆管空腸Roux-en-Y再建を施行しえた膵・胆管合流異常の1例
    高野 博信; 海老原 裕磨; 土川 貴裕; 田中 栄一; 七戸 俊明; 平野 聡, 日本内視鏡外科学会雑誌, 18, 6, 719, 724, Nov. 2013
    (一社)日本内視鏡外科学会, Japanese
  • 当科における完全腹腔鏡下噴門側胃切除・double tract再建術
    蔵前 太郎; 海老原 裕磨; 七戸 俊明; 高野 博信; 宮崎 大; 佐藤 暢人; 松村 祥幸; 倉島 庸; 村上 壮一; 田本 英司; 中村 透; 松本 譲; 土川 貴裕; 田中 栄一; 平野 聡, 日本内視鏡外科学会雑誌, 18, 7, 428, 428, Nov. 2013
    (一社)日本内視鏡外科学会, Japanese
  • 完全鏡視下に胆管切除・胆管空腸Roux-en-Y再建を施行し得た膵・胆管合流異常の1例
    高野 博信; 海老原 裕磨; 佐藤 暢人; 村上 壮一; 田本 英司; 倉島 庸; 中村 透; 松本 譲; 土川 貴裕; 田中 栄一; 七戸 俊明; 平野 聡, 日本内視鏡外科学会雑誌, 18, 7, 768, 768, Nov. 2013
    (一社)日本内視鏡外科学会, Japanese
  • 腹腔動脈合併尾側膵切除術(DP-CAR)後に壊死性胆嚢炎を来たした1例
    高野 博信; 松本 譲; 倉島 庸; 海老原 裕磨; 中村 透; 加藤 健太郎; 土川 貴裕; 田中 栄一; 七戸 俊明; 平野 聡, 日本消化器外科学会総会, 68回, P, 10, Jul. 2013
    (一社)日本消化器外科学会, Japanese
  • 術前化学療法後に肝左3区域切除兼動・門脈合併切除再建にて根治的手術を施行し得た肝門部胆管癌の1例
    高野 博信; 松本 譲; 中西 喜嗣; 浅野 賢道; 倉島 庸; 海老原 裕磨; 中村 透; 加藤 健太郎; 土川 貴裕; 田中 栄一; 七戸 俊明; 平野 聡, 日本肝胆膵外科学会・学術集会プログラム・抄録集, 25回, 421, 421, Jun. 2013
    (一社)日本肝胆膵外科学会, Japanese
  • 腹腔動脈合併尾側膵切除術(DP-CAR)後に壊死性胆嚢炎を来たした1例
    高野 博信; 松本 譲; 中西 喜嗣; 浅野 賢道; 倉島 庸; 海老原 裕磨; 中村 透; 加藤 健太郎; 土川 貴裕; 田中 栄一; 七戸 俊明; 平野 聡, 北海道外科雑誌, 58, 1, 80, 80, Jun. 2013
    北海道外科学会, Japanese
  • Reduced port surgeryの適応拡大 肺・縦隔疾患に対するneedle scopic surgeryの適応拡大
    加賀 基知三; 樋田 泰浩; 加藤 達哉; 石川 慶大; 中田 玲子; 高野 博信; 佐藤 彰記; 宮崎 大; 松居 喜郎, 日本外科学会雑誌, 114, 臨増2, 217, 217, Mar. 2013
    (一社)日本外科学会, Japanese
  • 区域切除 Hybrid or Complete VATS 完全胸腔鏡下肺区域切除と縦隔リンパ節郭清
    樋田 泰浩; 加賀 基知三; 加藤 達哉; 石川 慶大; 久保田 玲子[中田]; 佐藤 彰記; 高野 博信; 松居 喜郎, 日本内視鏡外科学会雑誌, 17, 7, 268, 268, Dec. 2012
    (一社)日本内視鏡外科学会, Japanese
  • 化学放射線療法後肺切除時の気管支断端瘻の予防
    樋田 泰浩; 加賀 基知三; 加藤 達哉; 石川 慶大; 中田 玲子[久保田]; 佐藤 彰記; 高野 博信; 松居 喜郎, 肺癌, 52, 5, 544, 544, Oct. 2012
    (NPO)日本肺癌学会, Japanese
  • 右肺癌に対する肺門縦隔郭清 右肺癌に対する完全胸腔鏡下縦隔郭清
    樋田 泰浩; 加賀 基知三; 加藤 達哉; 石川 慶大; 久保田 玲子[中田]; 佐藤 彰記; 高野 博信; 松居 喜郎, 日本臨床外科学会雑誌, 73, 増刊, 381, 381, Oct. 2012
    日本臨床外科学会, Japanese
  • 肺癌に対するReduced Port Video-assisted Thoracoscopic Surgeryの安全性
    高野 博信; 樋田 泰浩; 加賀 基知三; 加藤 達哉; 石川 慶大; 中田 玲子; 佐藤 彰記; 松居 喜郎, 日本臨床外科学会雑誌, 73, 増刊, 440, 440, Oct. 2012
    日本臨床外科学会, Japanese
  • 小型肺癌に対する胸腔鏡下術中生検法の検討 針生検と部分切除の比較
    石川 慶大; 加賀 基知三; 樋田 泰浩; 加藤 達哉; 久保田 玲子; 佐藤 彰記; 高野 博信; 松居 喜郎, 日本臨床外科学会雑誌, 73, 増刊, 827, 827, Oct. 2012
    日本臨床外科学会, Japanese
  • 若年女性に発症した小腸間膜デスモイド腫瘍の1例
    高野 博信; 福永 亮朗; 笹村 裕二; 武山 聡; 沼田 昭彦; 子野日 政昭, 北海道外科雑誌, 56, 2, 146, 146, Dec. 2011
    北海道外科学会, Japanese
  • 胆石胆嚢炎に合併した胆嚢仮性動脈瘤の1例
    高野 博信; 沼田 昭彦; 福永 亮朗; 笹村 裕二; 武山 聡; 子野日 政昭, 日本臨床外科学会雑誌, 72, 10, 2741, 2741, Oct. 2011
    日本臨床外科学会, Japanese
  • 当院における単孔式腹腔鏡下胆嚢摘出術の導入と初期成績
    田中 公貴; 児嶋 哲文; 平口 悦郎; 橋田 秀明; 吉岡 達也; 三井 潤; 高野 博信, 日本消化器外科学会雑誌, 44, Suppl.2, 179, 179, Oct. 2011
    (一社)日本消化器外科学会, Japanese
  • 塩酸イリノテカンが原因と思われる一過性の構語障害を来した1例
    曽我部 進; 結城 敏志; 高野 博信; 小林 良充; 中積 宏之; 佐々木 尚英; 川本 泰之; 福島 拓; 岩永 一郎; 上畠 寧子; 小松 嘉人; 浅香 正博, 癌と化学療法, 38, 8, 1375, 1377, Aug. 2011
    (株)癌と化学療法社, Japanese
  • 小児外傷性直腸穿孔に対し腹腔鏡下手術を施行した1例
    橋田 秀明; 高野 博信; 田中 公貴; 吉岡 達也; 平口 悦郎; 児嶋 哲文, 道南医学会大会並びに総会プログラム・抄録集, 63回, 52, 52, Nov. 2010
    道南医学会, Japanese
  • 4つの異なる組織型を呈した同時性一側多発乳癌の1例
    平口 悦郎; 児嶋 哲文; 橋田 秀明; 吉岡 達也; 田中 公貴; 高野 博信, 道南医学会大会並びに総会プログラム・抄録集, 63回, 53, 53, Nov. 2010
    道南医学会, Japanese
  • 膵仮性嚢胞と膵性胸水を伴ったアルコール性慢性膵炎に対しFrey手術が奏効した1例
    高野 博信; 児嶋 哲文; 平口 悦郎; 橋田 秀明; 吉岡 達也; 田中 公貴, 日本臨床外科学会雑誌, 71, 10, 2739, 2739, Oct. 2010
    日本臨床外科学会, Japanese
  • 当院健康管理センターにおける検診成績と課題
    吉岡 達也; 児嶋 哲文; 平口 悦郎; 橋田 秀明; 田中 公貴; 高野 博信; 石田 宏文, 日本乳癌検診学会誌, 19, 3, 361, 361, Oct. 2010
    (NPO)日本乳癌検診学会, Japanese
  • Frey手術が奏効したアルコール性慢性膵炎の1例
    高野 博信; 児嶋 哲文; 平口 悦郎; 橋田 秀明; 吉岡 達也; 田中 公貴, 日本臨床外科学会雑誌, 71, 増刊, 702, 702, Oct. 2010
    日本臨床外科学会, Japanese
  • 胸腔鏡・腹腔鏡併用により切除し得た食道胃接合部の巨大GISTの一例
    田中 公貴; 児嶋 哲文; 平口 悦郎; 橋田 秀明; 吉岡 達也; 高野 博信, 日本内視鏡外科学会雑誌, 15, 7, 565, 565, Oct. 2010
    (一社)日本内視鏡外科学会, Japanese
  • 上肢痛で発症した乳癌の1例
    吉岡 達也; 児嶋 哲文; 平口 悦郎; 橋田 秀明; 田中 公貴; 高野 博信, 日本癌治療学会誌, 45, 2, 772, 772, Sep. 2010
    (一社)日本癌治療学会, Japanese
  • 出血性ショックで発見され腹腔鏡補助下に切除した原発性小腸癌の1例
    寺本 賢一; 児嶋 哲文; 平口 悦郎; 橋田 秀明; 吉岡 達也; 宮谷内 健吾; 高野 博信, 日本臨床外科学会雑誌, 71, 5, 1368, 1368, May 2010
    日本臨床外科学会, Japanese
  • 腫瘤形成性膵炎と思われた膵癌の1例
    高野 博信; 児嶋 哲文; 平口 悦郎; 橋田 秀明; 寺本 賢一; 吉岡 達也; 宮谷内 健吾, 日本臨床外科学会雑誌, 71, 5, 1375, 1375, May 2010
    日本臨床外科学会, Japanese
  • 癌性リンパ管症を伴ったS状結腸癌に対して分子標的薬を併用した治療が奏効した1例
    曽我部 進; 結城 敏志; 高木 智史; 宮崎 拓自; 高野 博信; 川本 泰之; 中積 宏之; 佐々木 尚英; 岩永 一郎; 上畠 寧子; 浅香 正博; 小松 嘉人, 癌と化学療法, 37, 3, 535, 538, Mar. 2010
    (株)癌と化学療法社, Japanese
  • 下部胆管から十二指腸乳頭部に拡がる良悪性境界病変に対する膵温存胆管切断術 当科における3例の経験
    高野 博信; 田中 栄一; 土川 貴裕; 加藤 健太郎; 七戸 俊明; 平野 聡; 近藤 哲; 芦立 嘉智; 椎名 伸行; 田畑 祐希子; 中山 智英, 日本外科学会雑誌, 110, 臨増2, 799, 799, Feb. 2009
    (一社)日本外科学会, Japanese
  • 門脈内腫瘍栓を伴った腎癌多発膵転移の1例
    北井 秀典; 高野 博信; 田中 栄一; 土川 貴裕; 加藤 健太郎; 芦立 嘉智; 椎名 伸行; 田畑 佑希子; 中山 智英; 七戸 俊明; 平野 聡; 近藤 哲, 北海道外科雑誌, 53, 2, 222, 222, Dec. 2008
    北海道外科学会, Japanese
  • 総肝動脈の欠損があり胃小彎側動脈アーケードを温存して肝血流を確保し切除可能であった進行膵頭部癌の1例
    高野 博信, 北海道外科雑誌, 53, 2, 223, 223, Dec. 2008
    北海道外科学会, Japanese